Yh1 personal page - To The Moon

Yh1

Yh1

No personal profile

28Follow

2Followers

0Topic

0Badge

2023-08-02

$DELFI LIMITED(P34.SI)$

2021-09-08

Whalen is nano going up

2021-09-03

Wow. I miss the boat again

Bitcoin may be clearing resistance at 3-month high; Ether rallies to $4K

2021-09-03

Cloudfare go go go

2021-09-03

$Cloudflare, Inc.(NET)$Let’s go

2021-09-03

$Tesla Motors(TSLA)$Please hit 800

2021-09-03

$Tesla Motors(TSLA)$Please hit 800 please

2021-08-23

So share price is going up

Sorry, the original content has been removed

2021-07-23

Waiting foe growth stocks to go up.

Wall Street ekes out gains, led by tech, growth stocks

2021-07-21

To the moon

4 Dow Stocks With 48% to 58% Upside, According to Wall Street

2021-07-20

Let try to buy some good stocks.

$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years

2021-07-20

Is lemonade really a good stock?

A Market Crash Is Coming: 1 Growth Stock to Buy When It Happens

2021-07-10

AMC to the moon

Meme Stocks Like GameStop and AMC Reflect Market Reality

2021-07-10

Lousy stock, it just keep dropping. When are you going to go up

Tesla Shares Form Death Cross, Portending Further Declines

2021-07-06

Hopping all go to the moon

Advaxis Jumps on Deal to Be Bought by Biosight

2021-06-30

Interesting

L Brand's Victoria's Secret Seeks To Raise $500M Via Private Debt Offering

2021-05-06

$Luokung Technology Corp(LKCO)$Hopefully the stock will move to Ath now

2021-05-03

Let’s go higher

Dow jumps 200 points as stock market kicks off May in rally mode

2021-05-03

Way to go

U.S. stock benchmarks open higher to start May trade. Dow rose 1% for now

2021-04-30

Test

3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3558523389451047","uuid":"3558523389451047","gmtCreate":1595431279328,"gmtModify":1613569241844,"name":"Yh1","pinyin":"yh1","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":28,"tweetSize":60,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.31","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.47%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.72%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":204461710520560,"gmtCreate":1690950643394,"gmtModify":1690950645796,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P34.SI\">$DELFI LIMITED(P34.SI)$&nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/P34.SI\">$DELFI LIMITED(P34.SI)$&nbsp;</a>","text":"$DELFI LIMITED(P34.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/204461710520560","isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":889399728,"gmtCreate":1631108395764,"gmtModify":1676530469684,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Whalen is nano going up","listText":"Whalen is nano going up","text":"Whalen is nano going up","images":[{"img":"https://static.tigerbbs.com/13a8f68d2d2b577e725b154bf3ed339e","width":"750","height":"2326"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/889399728","isVote":1,"tweetType":1,"viewCount":495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":815224635,"gmtCreate":1630682163527,"gmtModify":1676530376287,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Wow. I miss the boat again","listText":"Wow. I miss the boat again","text":"Wow. I miss the boat again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/815224635","repostId":"1105876391","repostType":4,"repost":{"id":"1105876391","kind":"news","pubTimestamp":1630680345,"share":"https://ttm.financial/m/news/1105876391?lang=&edition=fundamental","pubTime":"2021-09-03 22:45","market":"other","language":"en","title":"Bitcoin may be clearing resistance at 3-month high; Ether rallies to $4K","url":"https://stock-news.laohu8.com/highlight/detail?id=1105876391","media":"seekingalpha","summary":"Recently, Ethereum has been on a tear, surging ~130% from its trough in mid-July, but Bitcoin contin","content":"<ul>\n <li>Recently, Ethereum&nbsp;has been on a tear,&nbsp;surging ~130%&nbsp;from its trough in mid-July, but Bitcoin&nbsp;continues to underperform Ether's price growth,&nbsp;climbing a mere ~75%&nbsp;in the same time frame.</li>\n <li>Ether&nbsp;is clearly ahead of the game, rising to 3-month highs on Wednesday, while Bitcoin (BTC-USD) rose to its highest level in&nbsp;three months on Friday.</li>\n <li>If the price of BTC fully breaks out of strong $50K resistance, there may be a case of 'fear of missing out', or FOMO traders coming back into the crypto market to take advantage of any upside momentum, Forex Trader Christopher Lewis notes in a&nbsp;blog post.</li>\n <li>Bitcoin's (BTC-USD) network hash rate has also improved from its trough in end-June, standing at 129.2 exahashes per second, which is already up 5 EH/s from the start of the week, implying more upside for BTC if the hash rate continues to climb,&nbsp;Cointelegraph reports.</li>\n</ul>\n<ul>\n <li>Bitcoin&nbsp;is testing $51K, while ETH flirts with $4K level.</li>\n <li>Bitcoin-related&nbsp;stocks&nbsp;were&nbsp;moving&nbsp;higher,BTCM&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;10%.</li>\n</ul>\n<ul>\n <p></p>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin may be clearing resistance at 3-month high; Ether rallies to $4K</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin may be clearing resistance at 3-month high; Ether rallies to $4K\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-03 22:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737159-bitcoin-finally-soars-to-3-month-high-ether-rallies-to-4k><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Recently, Ethereum has been on a tear, surging ~130% from its trough in mid-July, but Bitcoin continues to underperform Ether's price growth, climbing a mere ~75% in the same time frame.\nEther is ...</p>\n\n<a href=\"https://seekingalpha.com/news/3737159-bitcoin-finally-soars-to-3-month-high-ether-rallies-to-4k\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COIN":"Coinbase Global, Inc.","BTCM":"BIT Mining","FTFT":"富册金融科技"},"source_url":"https://seekingalpha.com/news/3737159-bitcoin-finally-soars-to-3-month-high-ether-rallies-to-4k","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1105876391","content_text":"Recently, Ethereum has been on a tear, surging ~130% from its trough in mid-July, but Bitcoin continues to underperform Ether's price growth, climbing a mere ~75% in the same time frame.\nEther is clearly ahead of the game, rising to 3-month highs on Wednesday, while Bitcoin (BTC-USD) rose to its highest level in three months on Friday.\nIf the price of BTC fully breaks out of strong $50K resistance, there may be a case of 'fear of missing out', or FOMO traders coming back into the crypto market to take advantage of any upside momentum, Forex Trader Christopher Lewis notes in a blog post.\nBitcoin's (BTC-USD) network hash rate has also improved from its trough in end-June, standing at 129.2 exahashes per second, which is already up 5 EH/s from the start of the week, implying more upside for BTC if the hash rate continues to climb, Cointelegraph reports.\n\n\nBitcoin is testing $51K, while ETH flirts with $4K level.\nBitcoin-related stocks were moving higher,BTCM shares rose nearly 10%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":706,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815225535,"gmtCreate":1630682120127,"gmtModify":1676530376271,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Cloudfare go go go","listText":"Cloudfare go go go","text":"Cloudfare go go go","images":[{"img":"https://static.tigerbbs.com/b8460287be535a4eefb1eaf8b9b8deb9","width":"750","height":"2380"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815225535","isVote":1,"tweetType":1,"viewCount":515,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":815225120,"gmtCreate":1630682074660,"gmtModify":1676530376207,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NET\">$Cloudflare, Inc.(NET)$</a>Let’s go","listText":"<a href=\"https://laohu8.com/S/NET\">$Cloudflare, Inc.(NET)$</a>Let’s go","text":"$Cloudflare, Inc.(NET)$Let’s go","images":[{"img":"https://static.tigerbbs.com/296237cbee25f8280a3698b253e013f9","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815225120","isVote":1,"tweetType":1,"viewCount":528,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":815222151,"gmtCreate":1630682018273,"gmtModify":1676530376184,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Please hit 800","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Please hit 800","text":"$Tesla Motors(TSLA)$Please hit 800","images":[{"img":"https://static.tigerbbs.com/d072a346ed5b0178d15b682d44f0f0c5","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815222151","isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":815222940,"gmtCreate":1630681997580,"gmtModify":1676530376184,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Please hit 800 please","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Please hit 800 please","text":"$Tesla Motors(TSLA)$Please hit 800 please","images":[{"img":"https://static.tigerbbs.com/d1e6bf431f084d64764686acaa4ac65b","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815222940","isVote":1,"tweetType":1,"viewCount":565,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":835537670,"gmtCreate":1629726539390,"gmtModify":1676530112878,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"So share price is going up","listText":"So share price is going up","text":"So share price is going up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/835537670","repostId":"1189910879","repostType":4,"isVote":1,"tweetType":1,"viewCount":561,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175455448,"gmtCreate":1627047698784,"gmtModify":1703483236263,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Waiting foe growth stocks to go up.","listText":"Waiting foe growth stocks to go up.","text":"Waiting foe growth stocks to go up.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/175455448","repostId":"1164478982","repostType":4,"repost":{"id":"1164478982","kind":"news","pubTimestamp":1626995319,"share":"https://ttm.financial/m/news/1164478982?lang=&edition=fundamental","pubTime":"2021-07-23 07:08","market":"us","language":"en","title":"Wall Street ekes out gains, led by tech, growth stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1164478982","media":"Reuters","summary":"NEW YORK  - Big tech helped Wall Street inch up to a higher close on Thursday, modestly building on a two-day rally as lackluster economic data and mixed corporate earnings prompted a pivot back to growth stocks.A pull-back in economically sensitive cyclicals kept the S&P 500’s and the blue-chip Dow’s gains muted, while small-caps underperformed their larger rivals.“The market is flip-flopping between the view that economic growth has almost peaked so you need to buy stocks that manufacture thei","content":"<p>NEW YORK (Reuters) - Big tech helped Wall Street inch up to a higher close on Thursday, modestly building on a two-day rally as lackluster economic data and mixed corporate earnings prompted a pivot back to growth stocks.</p>\n<p>A pull-back in economically sensitive cyclicals kept the S&amp;P 500’s and the blue-chip Dow’s gains muted, while small-caps underperformed their larger rivals.</p>\n<p>But megacap tech and tech-adjacent stocks, such as Microsoft Corp, Amazon.com, Apple Inc, <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc and Alphabet Inc, rose ahead of their quarterly results next week, putting the Nasdaq out front.</p>\n<p>All three major U.S. stock indexes ended the session within 1% of their record closing highs.</p>\n<p>Growth stocks, which outperformed throughout the health crisis, were back in favor, gaining 0.8%, while the value index slipped by 0.5%.</p>\n<p>“The market is flip-flopping between the view that economic growth has almost peaked so you need to buy stocks that manufacture their own growth like tech names, versus the view that economic growth will continue and you want to own cyclicals and value names,” said David Carter, chief investment officer at Lenox Wealth Advisors in New York.</p>\n<p>The number of U.S. workers filing first-time applications for unemployment benefits spiked unexpectedly to 419,000 last week, a two-month high, according to the Labor Department.</p>\n<p>Market participants are closely watching labor market indicators for hints as to when the Federal Reserve, expected to convene next week for its two-day monetary policy meeting, will begin discussions about hiking key interest rates from near zero.</p>\n<p>“The jobless data today didn’t have a meaningful impact on markets or the economic outlook,” Carter added. “It’s now all about how much longer the Fed will tolerate low rates. The Fed seems to be favoring its full employment mandate more than its price stability mandate.”</p>\n<p>“Accordingly, the upcoming Fed meeting could be impactful,” Carter said.</p>\n<p>Benchmark Treasury yields eased after the bid at the largest-ever TIPS auction touched a record low, pressuring rate sensitive banks.</p>\n<p>The Dow Jones Industrial Average rose 25.35 points, or 0.07%, to 34,823.35, the S&amp;P 500 gained 8.79 points, or 0.20%, to 4,367.48 and the Nasdaq Composite added 52.64 points, or 0.36%, to 14,684.60.</p>\n<p>Of the 11 major sectors of the S&amp;P 500, tech was shining brightest, gaining 0.7%. Energy stocks suffered the largest percentage drop.</p>\n<p>The second-quarter reporting season barreled ahead at full-throttle, with 104 of the companies in the S&amp;P 500 having reported. Of those, 88% have beaten consensus estimates, according to Refinitiv.</p>\n<p>Drugmaker Biogen Inc gained 1.1% after hiking its full-year revenue guidance, while Domino’s Pizza Inc surged 14.6% to an all-time high on the heels of its quarterly report.</p>\n<p>Southwest Airlines Co posted a bigger-than-expected quarterly loss, sending its stock down 3.5%, and American Airlines Group Inc dipped 1.1% even after reporting a quarterly profit.</p>\n<p>The S&amp;P 1500 Airlines index ended the session off 1.7%.</p>\n<p>Shares of Texas Instruments Inc slid 5.3% after its current-quarter revenue forecast cast concerns as to whether the company will be able to meet spiking demand in the face of a global semiconductor shortage.</p>\n<p>The Philadelphia SE Semiconductor index ended the session down 0.9%.</p>\n<p>Chipmaker Intel Corp slipped more than 1% in extended trading after the chipmaker posted results and raised its annual revenue forecast.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.82-to-1 ratio; on Nasdaq, a 1.90-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 39 new 52-week highs and no new lows; the Nasdaq Composite recorded 70 new highs and 54 new lows.</p>\n<p>Volume on U.S. exchanges was 8.25 billion shares, compared with the 10.12 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ekes out gains, led by tech, growth stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ekes out gains, led by tech, growth stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 07:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/usa-stocks/us-stocks-wall-street-ekes-out-gains-led-by-tech-growth-stocks-idUSL1N2OY2HH><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (Reuters) - Big tech helped Wall Street inch up to a higher close on Thursday, modestly building on a two-day rally as lackluster economic data and mixed corporate earnings prompted a pivot ...</p>\n\n<a href=\"https://www.reuters.com/article/usa-stocks/us-stocks-wall-street-ekes-out-gains-led-by-tech-growth-stocks-idUSL1N2OY2HH\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.reuters.com/article/usa-stocks/us-stocks-wall-street-ekes-out-gains-led-by-tech-growth-stocks-idUSL1N2OY2HH","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164478982","content_text":"NEW YORK (Reuters) - Big tech helped Wall Street inch up to a higher close on Thursday, modestly building on a two-day rally as lackluster economic data and mixed corporate earnings prompted a pivot back to growth stocks.\nA pull-back in economically sensitive cyclicals kept the S&P 500’s and the blue-chip Dow’s gains muted, while small-caps underperformed their larger rivals.\nBut megacap tech and tech-adjacent stocks, such as Microsoft Corp, Amazon.com, Apple Inc, Facebook Inc and Alphabet Inc, rose ahead of their quarterly results next week, putting the Nasdaq out front.\nAll three major U.S. stock indexes ended the session within 1% of their record closing highs.\nGrowth stocks, which outperformed throughout the health crisis, were back in favor, gaining 0.8%, while the value index slipped by 0.5%.\n“The market is flip-flopping between the view that economic growth has almost peaked so you need to buy stocks that manufacture their own growth like tech names, versus the view that economic growth will continue and you want to own cyclicals and value names,” said David Carter, chief investment officer at Lenox Wealth Advisors in New York.\nThe number of U.S. workers filing first-time applications for unemployment benefits spiked unexpectedly to 419,000 last week, a two-month high, according to the Labor Department.\nMarket participants are closely watching labor market indicators for hints as to when the Federal Reserve, expected to convene next week for its two-day monetary policy meeting, will begin discussions about hiking key interest rates from near zero.\n“The jobless data today didn’t have a meaningful impact on markets or the economic outlook,” Carter added. “It’s now all about how much longer the Fed will tolerate low rates. The Fed seems to be favoring its full employment mandate more than its price stability mandate.”\n“Accordingly, the upcoming Fed meeting could be impactful,” Carter said.\nBenchmark Treasury yields eased after the bid at the largest-ever TIPS auction touched a record low, pressuring rate sensitive banks.\nThe Dow Jones Industrial Average rose 25.35 points, or 0.07%, to 34,823.35, the S&P 500 gained 8.79 points, or 0.20%, to 4,367.48 and the Nasdaq Composite added 52.64 points, or 0.36%, to 14,684.60.\nOf the 11 major sectors of the S&P 500, tech was shining brightest, gaining 0.7%. Energy stocks suffered the largest percentage drop.\nThe second-quarter reporting season barreled ahead at full-throttle, with 104 of the companies in the S&P 500 having reported. Of those, 88% have beaten consensus estimates, according to Refinitiv.\nDrugmaker Biogen Inc gained 1.1% after hiking its full-year revenue guidance, while Domino’s Pizza Inc surged 14.6% to an all-time high on the heels of its quarterly report.\nSouthwest Airlines Co posted a bigger-than-expected quarterly loss, sending its stock down 3.5%, and American Airlines Group Inc dipped 1.1% even after reporting a quarterly profit.\nThe S&P 1500 Airlines index ended the session off 1.7%.\nShares of Texas Instruments Inc slid 5.3% after its current-quarter revenue forecast cast concerns as to whether the company will be able to meet spiking demand in the face of a global semiconductor shortage.\nThe Philadelphia SE Semiconductor index ended the session down 0.9%.\nChipmaker Intel Corp slipped more than 1% in extended trading after the chipmaker posted results and raised its annual revenue forecast.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.82-to-1 ratio; on Nasdaq, a 1.90-to-1 ratio favored decliners.\nThe S&P 500 posted 39 new 52-week highs and no new lows; the Nasdaq Composite recorded 70 new highs and 54 new lows.\nVolume on U.S. exchanges was 8.25 billion shares, compared with the 10.12 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":551,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176175478,"gmtCreate":1626874730994,"gmtModify":1703479693911,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"To the moon","listText":"To the moon","text":"To the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176175478","repostId":"2153610463","repostType":4,"repost":{"id":"2153610463","kind":"highlight","pubTimestamp":1626867600,"share":"https://ttm.financial/m/news/2153610463?lang=&edition=fundamental","pubTime":"2021-07-21 19:40","market":"us","language":"en","title":"4 Dow Stocks With 48% to 58% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2153610463","media":"Motley Fool","summary":"Are these Dow components the big-time bargains analysts make them out to be?","content":"<p>For the past 125 years, arguably no stock index has been more widely followed than the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI). The Dow Jones, which is comprised of 30 profitable, time-tested, multinational businesses, has become a barometer to gauge the health of the U.S. stock market.</p><p>It's also home to some serious value, at least according to a handful of Wall Street analysts and investment banks. Wall Street's high-water <a href=\"https://laohu8.com/S/AONE.U\">one</a>-year price target for each of the following four Dow stocks implies upside ranging from 48% to as much as 58%.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F634050%2Fnyse-wall-street-trading-new-york-financial-stock-market-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"484\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Intel: Implied upside of 55%</h3><p>To begin with, at least one Wall Street analyst foresees some significant upside in semiconductor giant <b>Intel</b> (NASDAQ:INTC). According to Robert W. Baird analyst Tristan Gerra, Intel could hit $85 a share, representing upside of 55% over the next year.</p><p>Among Gerra's chief arguments is that Intel will likely make a big acquisition to shore up its Foundry Services operations. It just so happens that <i>The Wall Street Journal</i> reported last week that Intel is tinkering with the idea of a $30 billion deal to acquire GlobalFoundries, a specialty chip-production company that <b>Advanced Micro Devices</b>&nbsp;spun off back in 2008. Going the acquisition route would emphasize Intel's renewed commitment to keep chip production under its own control, rather than outsource it. Depending on geopolitical or supply and demand concerns, that could become a major competitive edge for Intel.</p><p>Even though personal-computing chip demand tends to ebb and flow, the future for Intel will likely hinge on data centers. Despite a double-digit percentage decline in data center revenue in the first quarter, demand for storage, processing, and software solutions are only going to increase over the long run as businesses make the shift online and into the cloud.&nbsp; Intel's road will undoubtedly be bumpy as it spends big bucks on 7nm chip innovation, but it should prove well worth it.</p><p>An $85 price target may well make sense for Intel, but likely not over the next year.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F634050%2Fpharmacist-dispensing-drugs-patient-cost-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Walgreen Boots Alliance: Implied upside of 48%</h3><p>Healthcare stocks are also expected to get in on the action. Pharmacy chain <b><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a></b> (NASDAQ:WBA) has a high-end price target of $68 from analysts at Robert W. Baird. This portends up to 48% upside over the next 12 months.</p><p>The bullishness surrounding Walgreens likely has to do with the company's ongoing multipoint turnaround plan. By fiscal 2022, Walgreens should be realizing more than $2 billion in annual cost savings, yet at the same time will benefit from hefty investments in digitization. Although online sales only comprise a small portion of total sales, direct-to-consumer is an area of considerable growth opportunity for the generally slow-growing pharmacy chain.</p><p>Perhaps even more exciting is the partnership between Walgreens Boots Alliance and VillageMD. This duo plans to open as many as 700 full-service clinics (co-located in Walgreens' stores) in more than 30 markets throughout the United States by mid-decade.&nbsp; Whereas most in-store clinics cater to vaccines or a sniffle, doctor-led full-service practices inside Walgreens have the potential to facilitate repeat business and drive patients right to Walgreens' high-margin pharmacy.</p><p>As a shareholder, I'm enthusiastic about Walgreens' future. But I suspect it'll take longer than 12 months to reach $68.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F634050%2Fchemicals-manufacturing-plant-workers-steel-storage-tanks-tablet-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Dow Inc.: Implied upside of 58%</h3><p>When it comes to Dow stocks with supercharged return potential, chemicals company <b>Dow Inc.</b> (NYSE:DOW) takes the cake. If the Street-high price target of $95 were to come to fruition, Dow would return 58% for its shareholders over the coming year.</p><p>The biggest growth driver for Dow is going to be a continued U.S. and global recovery (Dow has a manufacturing presence in 31 countries). If economic activity continues to pick up, not only will the company recognize strong demand for its packaging, specialty plastics, performance materials, and coatings, but this demand will actually improve pricing power for Dow's material solutions. The first quarter saw demand and pricing power improve across all operating segments.</p><p>Beyond just growing demand, Dow is taking other actions to improve its bottom line. The company has invested aggressively in digitization, while at the same time restructuring its operations to eventually reduce costs by approximately $300 million on an annual basis. Perhaps most important, capacity expansion for its material solutions will allow Dow to meet increased demand as the U.S. and global economy heat up.</p><p>The bottom line is that Dow is a solid cyclical operating model that'll deliver incremental profit improvements in the years that lie ahead. But as a generally slower-growth business, $95 seems far too aggressive a price target over the coming 12 months.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F634050%2Foil-gas-refinery-downstreram-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"438\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Chevron: Implied upside of 54%</h3><p>Lastly, at least one Wall Street investment bank is counting on a gusher of a year from integrated oil and gas giant <b>Chevron</b> (NYSE:CVX). If the high-end price target of $152 proves accurate, Chevron could gallop higher by 54% over the coming year.</p><p>To state the obvious, Chevron benefits from its integrated operating model. Even though higher crude prices are more favorable given the juicier margin potential of its upstream (drilling and exploration) operations, the company is hedged by controlling petrochemical plants and refineries (downstream operations). When the price of crude declines, the input costs for its downstream operations fall, as well, pushing profitability and margins higher.</p><p>The Chevron growth story also can't be told without making mention of its generally superior balance sheet. Whereas most major oil stocks are weighed down by debt, Chevron's debt-to-equity of 34% is considerably lower than many of its peers. When combined with aggressive capital expenditure reductions in the near-term, Chevron looks to have considerably better financial flexibility than other oil majors.</p><p>Ultimately, Chevron's success will be dependent on a continued rebound in the U.S. and global economy. While history does indicate that periods of economic expansion usually last years, Wall Street's high-end price target should, once again, be taken with a grain of salt over the next year.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Dow Stocks With 48% to 58% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Dow Stocks With 48% to 58% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 19:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/21/4-dow-stocks-with-48-to-58-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For the past 125 years, arguably no stock index has been more widely followed than the Dow Jones Industrial Average (DJINDICES:^DJI). The Dow Jones, which is comprised of 30 profitable, time-tested, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/21/4-dow-stocks-with-48-to-58-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DOW":"陶氏化学","CVX":"雪佛龙","WBA":"沃尔格林联合博姿","09086":"华夏纳指-U","03086":"华夏纳指","INTC":"英特尔"},"source_url":"https://www.fool.com/investing/2021/07/21/4-dow-stocks-with-48-to-58-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153610463","content_text":"For the past 125 years, arguably no stock index has been more widely followed than the Dow Jones Industrial Average (DJINDICES:^DJI). The Dow Jones, which is comprised of 30 profitable, time-tested, multinational businesses, has become a barometer to gauge the health of the U.S. stock market.It's also home to some serious value, at least according to a handful of Wall Street analysts and investment banks. Wall Street's high-water one-year price target for each of the following four Dow stocks implies upside ranging from 48% to as much as 58%.Image source: Getty Images.Intel: Implied upside of 55%To begin with, at least one Wall Street analyst foresees some significant upside in semiconductor giant Intel (NASDAQ:INTC). According to Robert W. Baird analyst Tristan Gerra, Intel could hit $85 a share, representing upside of 55% over the next year.Among Gerra's chief arguments is that Intel will likely make a big acquisition to shore up its Foundry Services operations. It just so happens that The Wall Street Journal reported last week that Intel is tinkering with the idea of a $30 billion deal to acquire GlobalFoundries, a specialty chip-production company that Advanced Micro Devices spun off back in 2008. Going the acquisition route would emphasize Intel's renewed commitment to keep chip production under its own control, rather than outsource it. Depending on geopolitical or supply and demand concerns, that could become a major competitive edge for Intel.Even though personal-computing chip demand tends to ebb and flow, the future for Intel will likely hinge on data centers. Despite a double-digit percentage decline in data center revenue in the first quarter, demand for storage, processing, and software solutions are only going to increase over the long run as businesses make the shift online and into the cloud.  Intel's road will undoubtedly be bumpy as it spends big bucks on 7nm chip innovation, but it should prove well worth it.An $85 price target may well make sense for Intel, but likely not over the next year.Image source: Getty Images.Walgreen Boots Alliance: Implied upside of 48%Healthcare stocks are also expected to get in on the action. Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) has a high-end price target of $68 from analysts at Robert W. Baird. This portends up to 48% upside over the next 12 months.The bullishness surrounding Walgreens likely has to do with the company's ongoing multipoint turnaround plan. By fiscal 2022, Walgreens should be realizing more than $2 billion in annual cost savings, yet at the same time will benefit from hefty investments in digitization. Although online sales only comprise a small portion of total sales, direct-to-consumer is an area of considerable growth opportunity for the generally slow-growing pharmacy chain.Perhaps even more exciting is the partnership between Walgreens Boots Alliance and VillageMD. This duo plans to open as many as 700 full-service clinics (co-located in Walgreens' stores) in more than 30 markets throughout the United States by mid-decade.  Whereas most in-store clinics cater to vaccines or a sniffle, doctor-led full-service practices inside Walgreens have the potential to facilitate repeat business and drive patients right to Walgreens' high-margin pharmacy.As a shareholder, I'm enthusiastic about Walgreens' future. But I suspect it'll take longer than 12 months to reach $68.Image source: Getty Images.Dow Inc.: Implied upside of 58%When it comes to Dow stocks with supercharged return potential, chemicals company Dow Inc. (NYSE:DOW) takes the cake. If the Street-high price target of $95 were to come to fruition, Dow would return 58% for its shareholders over the coming year.The biggest growth driver for Dow is going to be a continued U.S. and global recovery (Dow has a manufacturing presence in 31 countries). If economic activity continues to pick up, not only will the company recognize strong demand for its packaging, specialty plastics, performance materials, and coatings, but this demand will actually improve pricing power for Dow's material solutions. The first quarter saw demand and pricing power improve across all operating segments.Beyond just growing demand, Dow is taking other actions to improve its bottom line. The company has invested aggressively in digitization, while at the same time restructuring its operations to eventually reduce costs by approximately $300 million on an annual basis. Perhaps most important, capacity expansion for its material solutions will allow Dow to meet increased demand as the U.S. and global economy heat up.The bottom line is that Dow is a solid cyclical operating model that'll deliver incremental profit improvements in the years that lie ahead. But as a generally slower-growth business, $95 seems far too aggressive a price target over the coming 12 months.Image source: Getty Images.Chevron: Implied upside of 54%Lastly, at least one Wall Street investment bank is counting on a gusher of a year from integrated oil and gas giant Chevron (NYSE:CVX). If the high-end price target of $152 proves accurate, Chevron could gallop higher by 54% over the coming year.To state the obvious, Chevron benefits from its integrated operating model. Even though higher crude prices are more favorable given the juicier margin potential of its upstream (drilling and exploration) operations, the company is hedged by controlling petrochemical plants and refineries (downstream operations). When the price of crude declines, the input costs for its downstream operations fall, as well, pushing profitability and margins higher.The Chevron growth story also can't be told without making mention of its generally superior balance sheet. Whereas most major oil stocks are weighed down by debt, Chevron's debt-to-equity of 34% is considerably lower than many of its peers. When combined with aggressive capital expenditure reductions in the near-term, Chevron looks to have considerably better financial flexibility than other oil majors.Ultimately, Chevron's success will be dependent on a continued rebound in the U.S. and global economy. While history does indicate that periods of economic expansion usually last years, Wall Street's high-end price target should, once again, be taken with a grain of salt over the next year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171872428,"gmtCreate":1626739855664,"gmtModify":1703764127582,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Let try to buy some good stocks.&nbsp;","listText":"Let try to buy some good stocks.&nbsp;","text":"Let try to buy some good stocks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/171872428","repostId":"2152483637","repostType":4,"repost":{"id":"2152483637","kind":"highlight","pubTimestamp":1626707880,"share":"https://ttm.financial/m/news/2152483637?lang=&edition=fundamental","pubTime":"2021-07-19 23:18","market":"us","language":"en","title":"$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2152483637","media":"Motley Fool","summary":"All three of them are well-positioned for tremendous growth.","content":"<blockquote>\n All three of them are well-positioned for tremendous growth.\n</blockquote>\n<p><b>Key <a href=\"https://laohu8.com/S/PCOM\">Points</a></b></p>\n<ul>\n <li>One stock should profit from the popularity of gaming and the increased adoption of artificial intelligence.</li>\n <li>Another stock is set to grow as it expands into new markets.</li>\n <li>The smallest of the three stocks offers a game-changing approach to diagnosing skin cancer.</li>\n</ul>\n<p>All you need is three ingredients to cook up sizzling stock returns. Those ingredients are a sufficient upfront amount of cash to invest, the right stocks to buy, and a long enough period of time.</p>\n<p>You might have noticed there are some vague words included in those ingredients, though: sufficient, right, long enough. How much upfront cash is sufficient? What are the \"right\" stocks to buy? How long is long enough to hold those stocks?</p>\n<p>The correct answers to those questions can vary. Some stocks don't require as big of an upfront investment or as lengthy of a holding period to generate tremendous returns as others do.</p>\n<p>However, I'll take a stab at answering all three questions in a way that is specific instead of vague. I think that $10,000 invested in these growth stocks could make you a fortune over the next 10 years.</p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3><a href=\"https://laohu8.com/S/NVDA\">NVIDIA Corp</a> </h3>\n<p>If you had invested $10,000 in&nbsp;<b>Nvidia</b> (NASDAQ:NVDA) a decade ago and held onto your shares, your investment would now be worth over $500,000. Will the stock deliver that kind of return over the next 10 years? Almost certainly not. However, I think that Nvidia will still be a huge winner for a long time to come.</p>\n<p>To be sure, there could be considerable volatility along the way. A cryptocurrency crash could pull down Nvidia's share price. It's happened in the past. The stock could also fall when the supply of chips catches up with demand.</p>\n<p>But over the long term, there are multiple tailwinds that work to Nvidia's advantage. One is the massive popularity of gaming with frequent upgrade cycles that drive demand for the company's latest graphics processing units. Another is the increased use of artificial intelligence in applications, which creates an expanding market for Nvidia as well.</p>\n<p>My view is that self-driving car technology will become a much larger opportunity for Nvidia over the next few years. I also expect that the proliferation of devices connected to the internet via 5G networks will also be a key growth driver for the company.</p>\n<p>Nvidia's market cap currently stands at close to $470 billion. I think the company can more than double its size over the next decade.</p>\n<h3><a href=\"https://laohu8.com/S/ETSY\">Etsy</a></h3>\n<p>You couldn't have invested any amount in<b>Etsy</b> (NASDAQ:ETSY) 10 years ago. The e-commerce company didn't list its shares on a public exchange until 2015. Since then, the stock has soared more than 500%. And Etsy has just begun to tap its potential.</p>\n<p>The company operates the go-to platform for buying unique hand-crafted products. Thanks to the COVID-19 pandemic, Etsy attracted lots of new customers. It also realized that its total addressable market was much bigger than it previously thought. Etsy CEO Josh Silverman put it this way: \"The size of Etsy's addressable market starts with a T not with a B.\"</p>\n<p>Etsy continues to enhance the product experience for customers to drive higher sales, including using strategic discounts and improving its search capabilities. It has also made a couple of acquisitions recently that give the company a presence in Latin America and in the fashion resale market.</p>\n<p>The company's market cap is less than $24 billion despite Etsy's tremendous growth. Although the stock trades at nearly 65 times expected earnings, I think that Etsy is actually cheap in light of its huge growth opportunity.</p>\n<h3><a href=\"https://laohu8.com/S/DMTK\">DermTech, Inc.</a> </h3>\n<p><b>DermTech</b> (NASDAQ:DMTK) is by far the smallest of these three growth stocks with its market cap below $1 billion. Unlike Nvidia and Etsy, the company isn't profitable yet. And DermTech hasn't delivered nearly as impressive gains. However, I believe that it could potentially make investors the most money over the next 10 years of the three stocks on the list.</p>\n<p>Great companies address big problems in a new way. That's exactly what DermTech is doing. It's trying to revolutionize how skin cancer is detected. The current approach requires visual inspection and surgical biopsy. DermTech uses non-invasive genomic testing. Adhesive patches are applied to the skin and then sent to a lab for analysis. No cutting is required.</p>\n<p>DermTech's skin genomics tests are 17 less likely to miss a diagnosis of melanoma than the current biopsy approach. And the cost of DermTech's method is significantly lower as well.</p>\n<p>The total annual market opportunity for DermTech including all types of skin cancer is around $10 billion. DermTech already has two products on the market for melanoma and continues to develop new products that will enable it to target other types of skin cancer. The company is still only in its early innings, but I expect that DermTech will be a big winner over the long term.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-19 23:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/19/10000-invested-in-these-growth-stocks-could-make-y/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>All three of them are well-positioned for tremendous growth.\n\nKey Points\n\nOne stock should profit from the popularity of gaming and the increased adoption of artificial intelligence.\nAnother stock is ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/19/10000-invested-in-these-growth-stocks-could-make-y/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/07/19/10000-invested-in-these-growth-stocks-could-make-y/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152483637","content_text":"All three of them are well-positioned for tremendous growth.\n\nKey Points\n\nOne stock should profit from the popularity of gaming and the increased adoption of artificial intelligence.\nAnother stock is set to grow as it expands into new markets.\nThe smallest of the three stocks offers a game-changing approach to diagnosing skin cancer.\n\nAll you need is three ingredients to cook up sizzling stock returns. Those ingredients are a sufficient upfront amount of cash to invest, the right stocks to buy, and a long enough period of time.\nYou might have noticed there are some vague words included in those ingredients, though: sufficient, right, long enough. How much upfront cash is sufficient? What are the \"right\" stocks to buy? How long is long enough to hold those stocks?\nThe correct answers to those questions can vary. Some stocks don't require as big of an upfront investment or as lengthy of a holding period to generate tremendous returns as others do.\nHowever, I'll take a stab at answering all three questions in a way that is specific instead of vague. I think that $10,000 invested in these growth stocks could make you a fortune over the next 10 years.\nImage source: Getty Images.\nNVIDIA Corp \nIf you had invested $10,000 in Nvidia (NASDAQ:NVDA) a decade ago and held onto your shares, your investment would now be worth over $500,000. Will the stock deliver that kind of return over the next 10 years? Almost certainly not. However, I think that Nvidia will still be a huge winner for a long time to come.\nTo be sure, there could be considerable volatility along the way. A cryptocurrency crash could pull down Nvidia's share price. It's happened in the past. The stock could also fall when the supply of chips catches up with demand.\nBut over the long term, there are multiple tailwinds that work to Nvidia's advantage. One is the massive popularity of gaming with frequent upgrade cycles that drive demand for the company's latest graphics processing units. Another is the increased use of artificial intelligence in applications, which creates an expanding market for Nvidia as well.\nMy view is that self-driving car technology will become a much larger opportunity for Nvidia over the next few years. I also expect that the proliferation of devices connected to the internet via 5G networks will also be a key growth driver for the company.\nNvidia's market cap currently stands at close to $470 billion. I think the company can more than double its size over the next decade.\nEtsy\nYou couldn't have invested any amount inEtsy (NASDAQ:ETSY) 10 years ago. The e-commerce company didn't list its shares on a public exchange until 2015. Since then, the stock has soared more than 500%. And Etsy has just begun to tap its potential.\nThe company operates the go-to platform for buying unique hand-crafted products. Thanks to the COVID-19 pandemic, Etsy attracted lots of new customers. It also realized that its total addressable market was much bigger than it previously thought. Etsy CEO Josh Silverman put it this way: \"The size of Etsy's addressable market starts with a T not with a B.\"\nEtsy continues to enhance the product experience for customers to drive higher sales, including using strategic discounts and improving its search capabilities. It has also made a couple of acquisitions recently that give the company a presence in Latin America and in the fashion resale market.\nThe company's market cap is less than $24 billion despite Etsy's tremendous growth. Although the stock trades at nearly 65 times expected earnings, I think that Etsy is actually cheap in light of its huge growth opportunity.\nDermTech, Inc. \nDermTech (NASDAQ:DMTK) is by far the smallest of these three growth stocks with its market cap below $1 billion. Unlike Nvidia and Etsy, the company isn't profitable yet. And DermTech hasn't delivered nearly as impressive gains. However, I believe that it could potentially make investors the most money over the next 10 years of the three stocks on the list.\nGreat companies address big problems in a new way. That's exactly what DermTech is doing. It's trying to revolutionize how skin cancer is detected. The current approach requires visual inspection and surgical biopsy. DermTech uses non-invasive genomic testing. Adhesive patches are applied to the skin and then sent to a lab for analysis. No cutting is required.\nDermTech's skin genomics tests are 17 less likely to miss a diagnosis of melanoma than the current biopsy approach. And the cost of DermTech's method is significantly lower as well.\nThe total annual market opportunity for DermTech including all types of skin cancer is around $10 billion. DermTech already has two products on the market for melanoma and continues to develop new products that will enable it to target other types of skin cancer. The company is still only in its early innings, but I expect that DermTech will be a big winner over the long term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":186,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171876027,"gmtCreate":1626739806969,"gmtModify":1703764124817,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Is lemonade really a good stock?","listText":"Is lemonade really a good stock?","text":"Is lemonade really a good stock?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171876027","repostId":"2152658489","repostType":4,"repost":{"id":"2152658489","kind":"highlight","pubTimestamp":1626707880,"share":"https://ttm.financial/m/news/2152658489?lang=&edition=fundamental","pubTime":"2021-07-19 23:18","market":"us","language":"en","title":"A Market Crash Is Coming: 1 Growth Stock to Buy When It Happens","url":"https://stock-news.laohu8.com/highlight/detail?id=2152658489","media":"Motley Fool","summary":"Having a game plan can help you avoid costly mistakes during a market crash.","content":"<p>The Federal Reserve has taken steps to stimulate the economy throughout the pandemic. For instance, interest rates are near historic lows, and the Fed continues to buy $120 billion in mortgage-backed securities and Treasury bonds each month. The goal behind these policies is to suppress the cost of borrowing while injecting cash into the economy.</p>\n<p>However, the economy is starting to look a little overheated. Last week, the U.S. Labor Department reported a 5.4% jump in the consumer price index (CPI) over the past 12 months, marking the biggest increase in over a decade. This has many investors concerned, because the CPI is used to gauge inflation, and in the past, rising inflation has often coincided with a market crash.</p>\n<p>More alarmingly, the Shiller P/E ratio -- which compares the price of the <b>S&amp;P 500</b> to the average inflation-adjusted earnings over the previous 10 years -- currently sits at 38. But prior to this time, the Shiller P/E has only exceeded 35 once in history: right before the dot-com bubble popped and the market crashed in 2000.</p>\n<p><img src=\"https://static.tigerbbs.com/3ca36c9b5ef5b57df19bc8d32ec089a2\" tg-width=\"700\" tg-height=\"496\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3><b>The good news</b></h3>\n<p>When the market goes down, stock prices can fall hard. The crash that started in 2000 saw the S&amp;P 500 plunge 49% before reaching its bottom. But there's a silver lining: Since that time, the S&amp;P 500 has still generated a return of over 7% per year. In other words, if you'd invested $10,000 in the index prior to the crash, it would be worth more than $40,000 today.</p>\n<p>Here's the big picture: Market crashes tend to be buying opportunities. Unfortunately, no <a href=\"https://laohu8.com/S/AONE.U\">one</a> knows exactly when the next big drop will happen, so the best thing you can do is prepare yourself. Set some cash aside and keep a list of high-quality stocks you'd like to own. For instance, I plan to buy more <b>Lemonade</b> (NYSE:LMND) during the next downturn. Here's why.</p>\n<p><img src=\"https://static.tigerbbs.com/7c52e7c0d66c57c1d4634fb0fccede1c\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3><a href=\"https://laohu8.com/S/LMND\">Lemonade, Inc.</a></h3>\n<p>Lemonade brings a disruptive mobile-first approach to the insurance industry. Instead of agents and actuaries -- people who sell policies and predict risk for traditional insurers -- Lemonade relies on chatbots and artificial intelligence, keeping payroll costs low relative to its rivals.</p>\n<p>Its platform is also designed to collect far more data than traditional systems. This advantage allows Lemonade to quantify risk, underwrite policies, and detect fraud more precisely, all of which translate into lower claims payments. Those savings&nbsp;can then be passed on to customers in the form of better prices, creating a virtuous cycle.</p>\n<p>In other words, as Lemonade adds new customers, more data is fed through its AI engine, sharpening its predictive capabilities. Over time, this makes Lemonade even better at mitigating risk, helping the company keep claims payments and policy prices low.</p>\n<p>It's still early, but this flywheel effect is already evident. Between 2018 and 2020, Lemonade's gross loss ratio (i.e., the percentage of premiums paid out in claims) dropped significantly. At the same time, its customer base grew quickly. In fact, it took Lemonade just over four years to reach <a href=\"https://laohu8.com/S/AONE.U\">one</a> million customers. By comparison, it took property and casualty insurance industry leader&nbsp;<a href=\"https://laohu8.com/S/STT\">State</a> Farm 22 years to hit the same milestone.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>2018</p></th>\n   <th><p>2020</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p><a href=\"https://laohu8.com/S/CUBI\">Customers</a></p></td>\n   <td width=\"156\"><p>308,835</p></td>\n   <td width=\"156\"><p>1.0 million</p></td>\n   <td width=\"156\"><p>80%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Gross loss ratio</p></td>\n   <td width=\"156\"><p>113%</p></td>\n   <td width=\"156\"><p>71%</p></td>\n   <td width=\"156\"><p>N/A</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Lemonade&nbsp;SEC filings. CAGR = compound annual growth rate.</p>\n<p>For context, State Farm's gross loss ratio in 2020&nbsp;was 72%. In other words, despite being a much younger company, Lemonade's AI-powered business incurred slightly lower losses (on a relative basis) than the industry leader. That's encouraging.</p>\n<p>However, Lemonade's gross loss ratio spiked to 121% in the first quarter of 2021. This was due to winter storm Uri in Texas, a black swan event beyond the predictive powers of AI. On the bright side, if losses from that catastrophe are excluded, Lemonade's gross loss ratio would have been 71% in the first quarter. That gives me confidence the company is on the right track.</p>\n<p>Looking ahead, Lemonade recently announced its next product: car insurance. Entering this industry adds $300 billion&nbsp;to its market opportunity in the U.S. alone, bringing the total to over $400 billion. In other words, this company has a long runway for growth, and insurance is a necessity whether we are in a bear or bull market.</p>\n<p>As a caveat, that doesn't mean a market crash wouldn't affect Lemonade. On the contrary, it's a small, unprofitable insurance company faced with much larger competitors, so its stock price would likely be volatile. But I'd use that as a buying opportunity to add more shares of this disruptive growth stock to my portfolio.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Market Crash Is Coming: 1 Growth Stock to Buy When It Happens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Market Crash Is Coming: 1 Growth Stock to Buy When It Happens\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-19 23:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/19/market-crash-is-coming-growth-stock-buy-lemonade/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Federal Reserve has taken steps to stimulate the economy throughout the pandemic. For instance, interest rates are near historic lows, and the Fed continues to buy $120 billion in mortgage-backed ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/19/market-crash-is-coming-growth-stock-buy-lemonade/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SSO":"两倍做多标普500ETF","LMND":"Lemonade, Inc.","OEF":"标普100指数ETF-iShares","SDS":"两倍做空标普500ETF","SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF","OEX":"标普100","UPRO":"三倍做多标普500ETF",".SPX":"S&P 500 Index","SH":"标普500反向ETF"},"source_url":"https://www.fool.com/investing/2021/07/19/market-crash-is-coming-growth-stock-buy-lemonade/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152658489","content_text":"The Federal Reserve has taken steps to stimulate the economy throughout the pandemic. For instance, interest rates are near historic lows, and the Fed continues to buy $120 billion in mortgage-backed securities and Treasury bonds each month. The goal behind these policies is to suppress the cost of borrowing while injecting cash into the economy.\nHowever, the economy is starting to look a little overheated. Last week, the U.S. Labor Department reported a 5.4% jump in the consumer price index (CPI) over the past 12 months, marking the biggest increase in over a decade. This has many investors concerned, because the CPI is used to gauge inflation, and in the past, rising inflation has often coincided with a market crash.\nMore alarmingly, the Shiller P/E ratio -- which compares the price of the S&P 500 to the average inflation-adjusted earnings over the previous 10 years -- currently sits at 38. But prior to this time, the Shiller P/E has only exceeded 35 once in history: right before the dot-com bubble popped and the market crashed in 2000.\n\nImage source: Getty Images.\nThe good news\nWhen the market goes down, stock prices can fall hard. The crash that started in 2000 saw the S&P 500 plunge 49% before reaching its bottom. But there's a silver lining: Since that time, the S&P 500 has still generated a return of over 7% per year. In other words, if you'd invested $10,000 in the index prior to the crash, it would be worth more than $40,000 today.\nHere's the big picture: Market crashes tend to be buying opportunities. Unfortunately, no one knows exactly when the next big drop will happen, so the best thing you can do is prepare yourself. Set some cash aside and keep a list of high-quality stocks you'd like to own. For instance, I plan to buy more Lemonade (NYSE:LMND) during the next downturn. Here's why.\n\nImage source: Getty Images.\nLemonade, Inc.\nLemonade brings a disruptive mobile-first approach to the insurance industry. Instead of agents and actuaries -- people who sell policies and predict risk for traditional insurers -- Lemonade relies on chatbots and artificial intelligence, keeping payroll costs low relative to its rivals.\nIts platform is also designed to collect far more data than traditional systems. This advantage allows Lemonade to quantify risk, underwrite policies, and detect fraud more precisely, all of which translate into lower claims payments. Those savings can then be passed on to customers in the form of better prices, creating a virtuous cycle.\nIn other words, as Lemonade adds new customers, more data is fed through its AI engine, sharpening its predictive capabilities. Over time, this makes Lemonade even better at mitigating risk, helping the company keep claims payments and policy prices low.\nIt's still early, but this flywheel effect is already evident. Between 2018 and 2020, Lemonade's gross loss ratio (i.e., the percentage of premiums paid out in claims) dropped significantly. At the same time, its customer base grew quickly. In fact, it took Lemonade just over four years to reach one million customers. By comparison, it took property and casualty insurance industry leader State Farm 22 years to hit the same milestone.\n\n\n\nMetric\n2018\n2020\nCAGR\n\n\n\n\nCustomers\n308,835\n1.0 million\n80%\n\n\nGross loss ratio\n113%\n71%\nN/A\n\n\n\nData source: Lemonade SEC filings. CAGR = compound annual growth rate.\nFor context, State Farm's gross loss ratio in 2020 was 72%. In other words, despite being a much younger company, Lemonade's AI-powered business incurred slightly lower losses (on a relative basis) than the industry leader. That's encouraging.\nHowever, Lemonade's gross loss ratio spiked to 121% in the first quarter of 2021. This was due to winter storm Uri in Texas, a black swan event beyond the predictive powers of AI. On the bright side, if losses from that catastrophe are excluded, Lemonade's gross loss ratio would have been 71% in the first quarter. That gives me confidence the company is on the right track.\nLooking ahead, Lemonade recently announced its next product: car insurance. Entering this industry adds $300 billion to its market opportunity in the U.S. alone, bringing the total to over $400 billion. In other words, this company has a long runway for growth, and insurance is a necessity whether we are in a bear or bull market.\nAs a caveat, that doesn't mean a market crash wouldn't affect Lemonade. On the contrary, it's a small, unprofitable insurance company faced with much larger competitors, so its stock price would likely be volatile. But I'd use that as a buying opportunity to add more shares of this disruptive growth stock to my portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141843140,"gmtCreate":1625850319980,"gmtModify":1703749926061,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"AMC to the moon&nbsp;","listText":"AMC to the moon&nbsp;","text":"AMC to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141843140","repostId":"1173374462","repostType":4,"repost":{"id":"1173374462","kind":"news","pubTimestamp":1625840008,"share":"https://ttm.financial/m/news/1173374462?lang=&edition=fundamental","pubTime":"2021-07-09 22:13","market":"us","language":"en","title":"Meme Stocks Like GameStop and AMC Reflect Market Reality","url":"https://stock-news.laohu8.com/highlight/detail?id=1173374462","media":"Thestreet","summary":"Gamestop (GME) made some investors rich… and then it broke many more. Investing in AMC Entertainment","content":"<p>Gamestop&nbsp;(<b>GME</b>)&nbsp;made some investors rich… and then it broke many more. Investing in AMC Entertainment&nbsp;(<b>AMC</b>)&nbsp;did the exact same thing. These two stocks represent, if not failing businesses, at least ailing ones; companies that struggled to keep up with the new economy even before the pandemic shut down large swaths of it. Yet over the past few months they have posted some of the most volatile gains and losses on the market.</p>\n<p>How?</p>\n<p>It’s down to what Real Money's Timothy Collins calls the market of “meme stock hyperbole.” But, he writes, is it really all that different from how trading has always worked?</p>\n<p>Have you ever really thought about the phrases 'to the moon' or 'conviction buy,' and how they mess with out perception of fair value?</p>\n<p>\"Initially, I rolled my eyes at the continued use of the phrase 'To The Moon,'\" Collins says. \"It's not like 'Strong Buy with a price target of $65', for instance. 'To the moon' is completely arbitrary and open to interpretation, but then again so are most things about valuation, when you think about it,\" Collins wrote.</p>\n<p>\"For instance, when an analyst pounds the table on a stock, how is that different from 'to the moon?' Or when someone says, 'all in.' Are they really all in? Did they cash in all their assets, pool the liquidity, and buy every share they possibly could? Probably not. Actually, I'd say definitely not 99.9999% of the time. Of course, there's always that one person,\" Collins said.</p>\n<p>\"But the point isWall Street has been arbitraryfor years. We can't even have a standard rating system. Is it 'Neutral' or 'Hold?' And really, do I want to hold something that is only in the middle of your range? No.\"</p>\n<p>Collins writes, \"The system should be 'buy' or 'sell.' That's it. Black or white. Own or don't own.\"</p>\n<p>Assets like GameStop and even cryptocurrency seem to be selling on nothing more than pure emotion. Investors are taking these products for a joy ride, and that tends to send prices flying up and down the ladder.</p>\n<p>That’s confusing, to be sure. Just, before you go throwing your hands in the air, it’s important to remember that the stock market has always been at least a little bit arbitrary.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Meme Stocks Like GameStop and AMC Reflect Market Reality</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMeme Stocks Like GameStop and AMC Reflect Market Reality\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 22:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/meme-stocks-like-gamestop-amc-reflect-market-reality><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gamestop (GME) made some investors rich… and then it broke many more. Investing in AMC Entertainment (AMC) did the exact same thing. These two stocks represent, if not failing businesses, at least ...</p>\n\n<a href=\"https://www.thestreet.com/investing/meme-stocks-like-gamestop-amc-reflect-market-reality\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","GME":"游戏驿站"},"source_url":"https://www.thestreet.com/investing/meme-stocks-like-gamestop-amc-reflect-market-reality","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173374462","content_text":"Gamestop (GME) made some investors rich… and then it broke many more. Investing in AMC Entertainment (AMC) did the exact same thing. These two stocks represent, if not failing businesses, at least ailing ones; companies that struggled to keep up with the new economy even before the pandemic shut down large swaths of it. Yet over the past few months they have posted some of the most volatile gains and losses on the market.\nHow?\nIt’s down to what Real Money's Timothy Collins calls the market of “meme stock hyperbole.” But, he writes, is it really all that different from how trading has always worked?\nHave you ever really thought about the phrases 'to the moon' or 'conviction buy,' and how they mess with out perception of fair value?\n\"Initially, I rolled my eyes at the continued use of the phrase 'To The Moon,'\" Collins says. \"It's not like 'Strong Buy with a price target of $65', for instance. 'To the moon' is completely arbitrary and open to interpretation, but then again so are most things about valuation, when you think about it,\" Collins wrote.\n\"For instance, when an analyst pounds the table on a stock, how is that different from 'to the moon?' Or when someone says, 'all in.' Are they really all in? Did they cash in all their assets, pool the liquidity, and buy every share they possibly could? Probably not. Actually, I'd say definitely not 99.9999% of the time. Of course, there's always that one person,\" Collins said.\n\"But the point isWall Street has been arbitraryfor years. We can't even have a standard rating system. Is it 'Neutral' or 'Hold?' And really, do I want to hold something that is only in the middle of your range? No.\"\nCollins writes, \"The system should be 'buy' or 'sell.' That's it. Black or white. Own or don't own.\"\nAssets like GameStop and even cryptocurrency seem to be selling on nothing more than pure emotion. Investors are taking these products for a joy ride, and that tends to send prices flying up and down the ladder.\nThat’s confusing, to be sure. Just, before you go throwing your hands in the air, it’s important to remember that the stock market has always been at least a little bit arbitrary.","news_type":1},"isVote":1,"tweetType":1,"viewCount":286,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141843914,"gmtCreate":1625850284538,"gmtModify":1703749925240,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Lousy stock, it just keep dropping. When are you going to go up","listText":"Lousy stock, it just keep dropping. When are you going to go up","text":"Lousy stock, it just keep dropping. When are you going to go up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141843914","repostId":"1158342403","repostType":4,"repost":{"id":"1158342403","kind":"news","pubTimestamp":1625840608,"share":"https://ttm.financial/m/news/1158342403?lang=&edition=fundamental","pubTime":"2021-07-09 22:23","market":"us","language":"en","title":"Tesla Shares Form Death Cross, Portending Further Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=1158342403","media":"Bloomberg","summary":"(Bloomberg) -- Tesla Inc. shares formed a trading pattern Friday that is closely watched by traders ","content":"<p><img src=\"https://static.tigerbbs.com/bb51ddaee6b764108c6a043b0481069f\" tg-width=\"704\" tg-height=\"396\" referrerpolicy=\"no-referrer\">(Bloomberg) -- Tesla Inc. shares formed a trading pattern Friday that is closely watched by traders as it often precedes further losses for the stock.</p>\n<p>The short-term average price for the stock fell below the long-term average, forming a so-called death cross. Shares of the electric vehicle maker have been on a rough ride already this year, falling 8%, even as the broader market rose nearly 16%.</p>\n<p>The decline reflects growing investor concern about competition from traditional carmakers that are pushing aggressively into the EV race, as well as the company’s future growth trajectory in China, which is among the world’s biggest markets for automobiles. On Thursday, Tesla unveiled a significantly cheaper version of its Model Y car in the country, even as its China deliveries dropped last month.</p>\n<p>The last time Tesla shares formed this trading pattern was in February 2019, and it preceded a more than 40% decline in the share price within 65 days, to $35.79 from $63.98.</p>\n<p>Tesla shares dropped as much as 1.2% on Friday in New York. Shares of smaller EV startups also languished, with Workhorse Group Inc. and XPeng Inc. among the biggest decliners in the group.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Shares Form Death Cross, Portending Further Declines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Shares Form Death Cross, Portending Further Declines\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 22:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/tesla-shares-form-death-cross-140046201.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Tesla Inc. shares formed a trading pattern Friday that is closely watched by traders as it often precedes further losses for the stock.\nThe short-term average price for the stock fell ...</p>\n\n<a href=\"https://finance.yahoo.com/news/tesla-shares-form-death-cross-140046201.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://finance.yahoo.com/news/tesla-shares-form-death-cross-140046201.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158342403","content_text":"(Bloomberg) -- Tesla Inc. shares formed a trading pattern Friday that is closely watched by traders as it often precedes further losses for the stock.\nThe short-term average price for the stock fell below the long-term average, forming a so-called death cross. Shares of the electric vehicle maker have been on a rough ride already this year, falling 8%, even as the broader market rose nearly 16%.\nThe decline reflects growing investor concern about competition from traditional carmakers that are pushing aggressively into the EV race, as well as the company’s future growth trajectory in China, which is among the world’s biggest markets for automobiles. On Thursday, Tesla unveiled a significantly cheaper version of its Model Y car in the country, even as its China deliveries dropped last month.\nThe last time Tesla shares formed this trading pattern was in February 2019, and it preceded a more than 40% decline in the share price within 65 days, to $35.79 from $63.98.\nTesla shares dropped as much as 1.2% on Friday in New York. Shares of smaller EV startups also languished, with Workhorse Group Inc. and XPeng Inc. among the biggest decliners in the group.","news_type":1},"isVote":1,"tweetType":1,"viewCount":139,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157660550,"gmtCreate":1625580558370,"gmtModify":1703744294705,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Hopping all go to the moon","listText":"Hopping all go to the moon","text":"Hopping all go to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157660550","repostId":"1118465420","repostType":4,"repost":{"id":"1118465420","kind":"news","pubTimestamp":1625580135,"share":"https://ttm.financial/m/news/1118465420?lang=&edition=fundamental","pubTime":"2021-07-06 22:02","market":"us","language":"en","title":"Advaxis Jumps on Deal to Be Bought by Biosight","url":"https://stock-news.laohu8.com/highlight/detail?id=1118465420","media":"Thestreet","summary":"Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Bi","content":"<p>Advaxis&nbsp;(<b>ADXS</b>)&nbsp;shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.</p>\n<p>At closing, Biosight holders will own 75%&nbsp;of the company and&nbsp;Advaxis holders will own 25%.</p>\n<p>Advaxis,&nbsp;Princeton, N.J.,&nbsp;recently traded at 70 cents a share, up 48%. It had gained 5% in the six months through Friday.</p>\n<p>The combined company will be named Biosight Therapeutics and trade on Nasdaq with the ticker symbol BSTX.</p>\n<p>“The proposed merger will create a public company that will prioritize the clinical advancement and commercialization of Biosight’s lead product, aspacytarabine,” the companies said. That drug treats acute myeloid leukemia.</p>\n<p>The new company is expected to have some $50 million cash, cash equivalents and marketable securities. The deal is expected to close in the second half, subject to conditions including regulatory clearances and votes of holders of both companies.</p>\n<p>In other healthcare news, Iterum Therapeutics&nbsp;(<b>ITRM</b>) -Get Report&nbsp;said Friday that it received a letterfrom the FDA saying that deficiencies in its treatment for urinary-tract infections&nbsp;were found.</p>\n<p>The Food and Drug Administration letter stated that as “part of their ongoing review of the company’s new drug application for sulopenem etzadroxil/probenecid, the agency has identified deficiencies that preclude the continuation of the discussion of labeling and post-marketing requirements/commitments at this time,” Iterum said.</p>\n<p>Also last week,Anavex Life Sciences&nbsp;(<b>AVXL</b>) -Get Report&nbsp;reported progress in a Phase 2 trial of a Parkinson’s drug, Anavex2-73.</p>\n<p>JonesTrading analyst Soumit Roy raised his price target on the New York company to $50 from $35, affirming a buy rating.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Advaxis Jumps on Deal to Be Bought by Biosight</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdvaxis Jumps on Deal to Be Bought by Biosight\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-06 22:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.\nAt closing, Biosight holders will own 75% of the company and ...</p>\n\n<a href=\"https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADXS":"Ayala Pharmaceuticals, Inc."},"source_url":"https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118465420","content_text":"Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.\nAt closing, Biosight holders will own 75% of the company and Advaxis holders will own 25%.\nAdvaxis, Princeton, N.J., recently traded at 70 cents a share, up 48%. It had gained 5% in the six months through Friday.\nThe combined company will be named Biosight Therapeutics and trade on Nasdaq with the ticker symbol BSTX.\n“The proposed merger will create a public company that will prioritize the clinical advancement and commercialization of Biosight’s lead product, aspacytarabine,” the companies said. That drug treats acute myeloid leukemia.\nThe new company is expected to have some $50 million cash, cash equivalents and marketable securities. The deal is expected to close in the second half, subject to conditions including regulatory clearances and votes of holders of both companies.\nIn other healthcare news, Iterum Therapeutics (ITRM) -Get Report said Friday that it received a letterfrom the FDA saying that deficiencies in its treatment for urinary-tract infections were found.\nThe Food and Drug Administration letter stated that as “part of their ongoing review of the company’s new drug application for sulopenem etzadroxil/probenecid, the agency has identified deficiencies that preclude the continuation of the discussion of labeling and post-marketing requirements/commitments at this time,” Iterum said.\nAlso last week,Anavex Life Sciences (AVXL) -Get Report reported progress in a Phase 2 trial of a Parkinson’s drug, Anavex2-73.\nJonesTrading analyst Soumit Roy raised his price target on the New York company to $50 from $35, affirming a buy rating.","news_type":1},"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":153186048,"gmtCreate":1625013621284,"gmtModify":1703850040995,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/153186048","repostId":"2147898672","repostType":4,"repost":{"id":"2147898672","kind":"news","pubTimestamp":1625013017,"share":"https://ttm.financial/m/news/2147898672?lang=&edition=fundamental","pubTime":"2021-06-30 08:30","market":"us","language":"en","title":"L Brand's Victoria's Secret Seeks To Raise $500M Via Private Debt Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2147898672","media":"Benzinga","summary":"$L Brands Inc$  has announced its subsidiary, Victoria’s Secret & Co, is offering to sell $500 million in aggregate principal amount of senior unsecured notes due 2029 in a private offering.Victoria’s Secret will use the proceeds from the Notes offering, after deducting discounts and commissions to the initial purchasers of the Notes and estimated offering expenses, to fund a portion of a cash payment to L Brands.Pending completion of the Separation proceeds from the offering of the Notes will b","content":"<ul>\n <li><b><a href=\"https://laohu8.com/S/LB\">L Brands Inc</a>&nbsp;</b>(NYSE: LB)&nbsp;has announced&nbsp;its subsidiary, Victoria’s Secret &amp; Co, is offering to sell $500 million in aggregate principal amount of senior unsecured notes due 2029 in a private offering.</li>\n <li>Victoria’s Secret will use the proceeds from the Notes offering, after deducting discounts and commissions to the initial purchasers of the Notes and estimated offering expenses, to fund a portion of a cash payment to L Brands.</li>\n <li>Pending completion of the Separation proceeds from the offering of the Notes will be deposited into escrow to benefit the holders of the Notes.</li>\n <li>America’s biggest lingerie retailer is preparing to become a standalone company, Victoria’s Secret &amp; Co, spun off from parent L Brands.</li>\n <li>L Brands’ cash and equivalents totaled $2.8 billion as of April 30, 2021.</li>\n <li><b>Price action:</b>&nbsp;LB shares closed higher by 0.34% at $71.21 on Tuesday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>L Brand's Victoria's Secret Seeks To Raise $500M Via Private Debt Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nL Brand's Victoria's Secret Seeks To Raise $500M Via Private Debt Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 08:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/l-brands-victorias-secret-seeks-203417230.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>L Brands Inc (NYSE: LB) has announced its subsidiary, Victoria’s Secret & Co, is offering to sell $500 million in aggregate principal amount of senior unsecured notes due 2029 in a private offering.\n...</p>\n\n<a href=\"https://finance.yahoo.com/news/l-brands-victorias-secret-seeks-203417230.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LB":"LandBridge Co. LLC"},"source_url":"https://finance.yahoo.com/news/l-brands-victorias-secret-seeks-203417230.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2147898672","content_text":"L Brands Inc (NYSE: LB) has announced its subsidiary, Victoria’s Secret & Co, is offering to sell $500 million in aggregate principal amount of senior unsecured notes due 2029 in a private offering.\nVictoria’s Secret will use the proceeds from the Notes offering, after deducting discounts and commissions to the initial purchasers of the Notes and estimated offering expenses, to fund a portion of a cash payment to L Brands.\nPending completion of the Separation proceeds from the offering of the Notes will be deposited into escrow to benefit the holders of the Notes.\nAmerica’s biggest lingerie retailer is preparing to become a standalone company, Victoria’s Secret & Co, spun off from parent L Brands.\nL Brands’ cash and equivalents totaled $2.8 billion as of April 30, 2021.\nPrice action: LB shares closed higher by 0.34% at $71.21 on Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":105854636,"gmtCreate":1620292065625,"gmtModify":1704341435727,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>Hopefully the stock will move to Ath now","listText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>Hopefully the stock will move to Ath now","text":"$Luokung Technology Corp(LKCO)$Hopefully the stock will move to Ath now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/105854636","isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":108452817,"gmtCreate":1620050758939,"gmtModify":1704337917607,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Let’s go higher","listText":"Let’s go higher","text":"Let’s go higher","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/108452817","repostId":"1165463758","repostType":4,"repost":{"id":"1165463758","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620048819,"share":"https://ttm.financial/m/news/1165463758?lang=&edition=fundamental","pubTime":"2021-05-03 21:33","market":"us","language":"en","title":"Dow jumps 200 points as stock market kicks off May in rally mode","url":"https://stock-news.laohu8.com/highlight/detail?id=1165463758","media":"Tiger Newspress","summary":"(May 3) Stocks opened higher Monday, kicking off the first trading day of May in rally mode as inves","content":"<p>(May 3)&nbsp;Stocks opened higher Monday, kicking off the first trading day of May in rally mode as investors bet on the reopening of the U.S. economy. The Dow Jones Industrial Average&nbsp;was up 200 points, or 0.6%, at 34,076, while the S&amp;P 500&nbsp;rose 0.5% to 4,203 and the Nasdaq Composite&nbsp;advanced 0.4% to 14,012.</p><p>Berkshire Hathaway shares rose 1% in early trading after Warren Buffett’s conglomeratereported a 20% surge in operating earningsand continued to buy back large amounts of its own shares. Buffett also revealed to CNBC that when he is no longer in charge, Greg Abel, vice chairman of all non-insurance operations,will succeed him.</p><p>Bets on the economic reopening were gaining in early trading. Norwegian Cruise Line holdings and Carnival Corp. were both higher by 1% in the premarket. Caterpillar and Bank of America were also higher.</p><p>Shares of Verizon rose 0.6% in premarket trading after the telecom giant saidit will sell its media group to private equity firm Apollo Global Managementfor $5 billion. The sale allows Verizon to offload properties from the former internet empires of AOL and Yahoo.</p><p>Some tech shares, such as Tesla and Netflix, were weak in early trading.</p><p>Monday marks the first trading day of May. Despite Friday’s weakness in equities, the S&amp;P 500 notched its third straight month of gains in April, adding more than 5% to the index as investors bet on a big economic and profit recovery from the pandemic.</p><p>The S&amp;P 500 is now up 11% for the year.&nbsp;The benchmark closed at record levels on Thursday&nbsp;on the heels of blowout earnings results from Apple and Facebook.</p><p>The Dow rose about 2.7% last month, while the Nasdaq Composite gained 5.4% in April.</p><p>Some investors are expecting weakness in the new month given the old \"sell in May and go away\" Wall Street adage. This mantra calls for taking off risk from May to October, a period where the market is more prone to sell-offs historically.</p><p>Data going back to 1928 shows that the May-October period has the lowest average and median returns of any six-month period of the year with the S&amp;P 500 up 66% of the time on an average return of 2.2%, according to Bank of America.</p><p>The market might see mediocre performance from here especially after a massive rally from November to April, where the S&amp;P 500 gained 28%, the bank noted.</p><p>\"This is a small number of observations, but May-October has lackluster average and median returns after a November-April rally of at least 20%,\" Stephen Suttmeier, technical research strategist at Bank of America, said in a note.</p><p>Manufacturing PMI data for April will be released at 9:45 a.m. ET on Monday, followed by ISM manufacturing at 10 a.m.</p><p>April's jobs report will be released on Friday.</p><p>\"Investors are gearing up for another busy earnings week capped off with a widely watched jobs report. Given the positive economic and earnings news, the path of least resistance appears higher,\" Jack Ablin, chief investment officer at Cresset Capital told CNBC.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow jumps 200 points as stock market kicks off May in rally mode</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow jumps 200 points as stock market kicks off May in rally mode\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-03 21:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(May 3)&nbsp;Stocks opened higher Monday, kicking off the first trading day of May in rally mode as investors bet on the reopening of the U.S. economy. The Dow Jones Industrial Average&nbsp;was up 200 points, or 0.6%, at 34,076, while the S&amp;P 500&nbsp;rose 0.5% to 4,203 and the Nasdaq Composite&nbsp;advanced 0.4% to 14,012.</p><p>Berkshire Hathaway shares rose 1% in early trading after Warren Buffett’s conglomeratereported a 20% surge in operating earningsand continued to buy back large amounts of its own shares. Buffett also revealed to CNBC that when he is no longer in charge, Greg Abel, vice chairman of all non-insurance operations,will succeed him.</p><p>Bets on the economic reopening were gaining in early trading. Norwegian Cruise Line holdings and Carnival Corp. were both higher by 1% in the premarket. Caterpillar and Bank of America were also higher.</p><p>Shares of Verizon rose 0.6% in premarket trading after the telecom giant saidit will sell its media group to private equity firm Apollo Global Managementfor $5 billion. The sale allows Verizon to offload properties from the former internet empires of AOL and Yahoo.</p><p>Some tech shares, such as Tesla and Netflix, were weak in early trading.</p><p>Monday marks the first trading day of May. Despite Friday’s weakness in equities, the S&amp;P 500 notched its third straight month of gains in April, adding more than 5% to the index as investors bet on a big economic and profit recovery from the pandemic.</p><p>The S&amp;P 500 is now up 11% for the year.&nbsp;The benchmark closed at record levels on Thursday&nbsp;on the heels of blowout earnings results from Apple and Facebook.</p><p>The Dow rose about 2.7% last month, while the Nasdaq Composite gained 5.4% in April.</p><p>Some investors are expecting weakness in the new month given the old \"sell in May and go away\" Wall Street adage. This mantra calls for taking off risk from May to October, a period where the market is more prone to sell-offs historically.</p><p>Data going back to 1928 shows that the May-October period has the lowest average and median returns of any six-month period of the year with the S&amp;P 500 up 66% of the time on an average return of 2.2%, according to Bank of America.</p><p>The market might see mediocre performance from here especially after a massive rally from November to April, where the S&amp;P 500 gained 28%, the bank noted.</p><p>\"This is a small number of observations, but May-October has lackluster average and median returns after a November-April rally of at least 20%,\" Stephen Suttmeier, technical research strategist at Bank of America, said in a note.</p><p>Manufacturing PMI data for April will be released at 9:45 a.m. ET on Monday, followed by ISM manufacturing at 10 a.m.</p><p>April's jobs report will be released on Friday.</p><p>\"Investors are gearing up for another busy earnings week capped off with a widely watched jobs report. Given the positive economic and earnings news, the path of least resistance appears higher,\" Jack Ablin, chief investment officer at Cresset Capital told CNBC.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165463758","content_text":"(May 3) Stocks opened higher Monday, kicking off the first trading day of May in rally mode as investors bet on the reopening of the U.S. economy. The Dow Jones Industrial Average was up 200 points, or 0.6%, at 34,076, while the S&P 500 rose 0.5% to 4,203 and the Nasdaq Composite advanced 0.4% to 14,012.Berkshire Hathaway shares rose 1% in early trading after Warren Buffett’s conglomeratereported a 20% surge in operating earningsand continued to buy back large amounts of its own shares. Buffett also revealed to CNBC that when he is no longer in charge, Greg Abel, vice chairman of all non-insurance operations,will succeed him.Bets on the economic reopening were gaining in early trading. Norwegian Cruise Line holdings and Carnival Corp. were both higher by 1% in the premarket. Caterpillar and Bank of America were also higher.Shares of Verizon rose 0.6% in premarket trading after the telecom giant saidit will sell its media group to private equity firm Apollo Global Managementfor $5 billion. The sale allows Verizon to offload properties from the former internet empires of AOL and Yahoo.Some tech shares, such as Tesla and Netflix, were weak in early trading.Monday marks the first trading day of May. Despite Friday’s weakness in equities, the S&P 500 notched its third straight month of gains in April, adding more than 5% to the index as investors bet on a big economic and profit recovery from the pandemic.The S&P 500 is now up 11% for the year. The benchmark closed at record levels on Thursday on the heels of blowout earnings results from Apple and Facebook.The Dow rose about 2.7% last month, while the Nasdaq Composite gained 5.4% in April.Some investors are expecting weakness in the new month given the old \"sell in May and go away\" Wall Street adage. This mantra calls for taking off risk from May to October, a period where the market is more prone to sell-offs historically.Data going back to 1928 shows that the May-October period has the lowest average and median returns of any six-month period of the year with the S&P 500 up 66% of the time on an average return of 2.2%, according to Bank of America.The market might see mediocre performance from here especially after a massive rally from November to April, where the S&P 500 gained 28%, the bank noted.\"This is a small number of observations, but May-October has lackluster average and median returns after a November-April rally of at least 20%,\" Stephen Suttmeier, technical research strategist at Bank of America, said in a note.Manufacturing PMI data for April will be released at 9:45 a.m. ET on Monday, followed by ISM manufacturing at 10 a.m.April's jobs report will be released on Friday.\"Investors are gearing up for another busy earnings week capped off with a widely watched jobs report. Given the positive economic and earnings news, the path of least resistance appears higher,\" Jack Ablin, chief investment officer at Cresset Capital told CNBC.","news_type":1},"isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":108456791,"gmtCreate":1620050741613,"gmtModify":1704337918094,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Way to go","listText":"Way to go","text":"Way to go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/108456791","repostId":"1125593862","repostType":4,"repost":{"id":"1125593862","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620050268,"share":"https://ttm.financial/m/news/1125593862?lang=&edition=fundamental","pubTime":"2021-05-03 21:57","market":"us","language":"en","title":"U.S. stock benchmarks open higher to start May trade. Dow rose 1% for now","url":"https://stock-news.laohu8.com/highlight/detail?id=1125593862","media":"Tiger Newspress","summary":"(May 3) U.S. stock benchmarks open higher to start May trade. Dow rose 1% for now.","content":"<p>(May&nbsp;3)&nbsp;U.S. stock benchmarks open higher to start May trade. Dow rose 1% for now.</p><p><img src=\"https://static.tigerbbs.com/b00fdc29ae0463ac42f782eb04e4ab06\" tg-width=\"911\" tg-height=\"479\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stock benchmarks open higher to start May trade. Dow rose 1% for now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stock benchmarks open higher to start May trade. Dow rose 1% for now\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-03 21:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(May&nbsp;3)&nbsp;U.S. stock benchmarks open higher to start May trade. Dow rose 1% for now.</p><p><img src=\"https://static.tigerbbs.com/b00fdc29ae0463ac42f782eb04e4ab06\" tg-width=\"911\" tg-height=\"479\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125593862","content_text":"(May 3) U.S. stock benchmarks open higher to start May trade. Dow rose 1% for now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103571741,"gmtCreate":1619796641183,"gmtModify":1704272563996,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Test","listText":"Test","text":"Test","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/103571741","repostId":"1165708828","repostType":4,"repost":{"id":"1165708828","kind":"news","pubTimestamp":1619792862,"share":"https://ttm.financial/m/news/1165708828?lang=&edition=fundamental","pubTime":"2021-04-30 22:27","market":"us","language":"en","title":"3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1165708828","media":"Motley Fool","summary":"For more than a year, patient investors have been handsomely rewarded. All three of the market's maj","content":"<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.</p>\n<p>Yet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in the<b>S&amp;P 500</b>,<b>Dow Jones Industrial Average</b>, and<b>Nasdaq Composite</b>, this represents a huge underperformance.</p>\n<p>But according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.</p>\n<p>Sarepta Therapeutics: Implied upside of 91%</p>\n<p>Many of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developer<b>Sarepta Therapeutics</b>(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.</p>\n<p>Sarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.</p>\n<p>However, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.&nbsp; In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.</p>\n<p>The Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.</p>\n<p>Intercept Pharmaceuticals: Implied upside of 97%</p>\n<p>If you wanteven more upside potential, Wall Street would steer you toward small-cap<b>Intercept Pharmaceuticals</b>(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.</p>\n<p>Similar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.</p>\n<p>Intercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.</p>\n<p>On the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.</p>\n<p>If OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.</p>\n<p>It's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.</p>\n<p>Inovio Pharmaceuticals: Implied upside of 104%</p>\n<p>Yet another biotech stock withbig-time upside potential, according to Wall Street, is<b>Inovio Pharmaceuticals</b>(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.</p>\n<p>For much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.</p>\n<p>Unfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.</p>\n<p>There are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players like<b>Johnson &amp; Johnson</b>&nbsp;can produce up to 3 billion doses for the global market this year. As a reminder, J&amp;J's vaccine is a single-dose treatment.</p>\n<p>The other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.</p>\n<p>With a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 22:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165708828","content_text":"For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.\nYet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in theS&P 500,Dow Jones Industrial Average, andNasdaq Composite, this represents a huge underperformance.\nBut according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.\nSarepta Therapeutics: Implied upside of 91%\nMany of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developerSarepta Therapeutics(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.\nSarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.\nHowever, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.  In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.\nThe Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.\nIntercept Pharmaceuticals: Implied upside of 97%\nIf you wanteven more upside potential, Wall Street would steer you toward small-capIntercept Pharmaceuticals(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.\nSimilar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.\nIntercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.\nOn the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.\nIf OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.\nIt's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.\nInovio Pharmaceuticals: Implied upside of 104%\nYet another biotech stock withbig-time upside potential, according to Wall Street, isInovio Pharmaceuticals(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.\nFor much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.\nUnfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.\nThere are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players likeJohnson & Johnson can produce up to 3 billion doses for the global market this year. As a reminder, J&J's vaccine is a single-dose treatment.\nThe other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.\nWith a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.","news_type":1},"isVote":1,"tweetType":1,"viewCount":154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":175455448,"gmtCreate":1627047698784,"gmtModify":1703483236263,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Waiting foe growth stocks to go up.","listText":"Waiting foe growth stocks to go up.","text":"Waiting foe growth stocks to go up.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/175455448","repostId":"1164478982","repostType":4,"repost":{"id":"1164478982","kind":"news","pubTimestamp":1626995319,"share":"https://ttm.financial/m/news/1164478982?lang=&edition=fundamental","pubTime":"2021-07-23 07:08","market":"us","language":"en","title":"Wall Street ekes out gains, led by tech, growth stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1164478982","media":"Reuters","summary":"NEW YORK  - Big tech helped Wall Street inch up to a higher close on Thursday, modestly building on a two-day rally as lackluster economic data and mixed corporate earnings prompted a pivot back to growth stocks.A pull-back in economically sensitive cyclicals kept the S&P 500’s and the blue-chip Dow’s gains muted, while small-caps underperformed their larger rivals.“The market is flip-flopping between the view that economic growth has almost peaked so you need to buy stocks that manufacture thei","content":"<p>NEW YORK (Reuters) - Big tech helped Wall Street inch up to a higher close on Thursday, modestly building on a two-day rally as lackluster economic data and mixed corporate earnings prompted a pivot back to growth stocks.</p>\n<p>A pull-back in economically sensitive cyclicals kept the S&amp;P 500’s and the blue-chip Dow’s gains muted, while small-caps underperformed their larger rivals.</p>\n<p>But megacap tech and tech-adjacent stocks, such as Microsoft Corp, Amazon.com, Apple Inc, <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc and Alphabet Inc, rose ahead of their quarterly results next week, putting the Nasdaq out front.</p>\n<p>All three major U.S. stock indexes ended the session within 1% of their record closing highs.</p>\n<p>Growth stocks, which outperformed throughout the health crisis, were back in favor, gaining 0.8%, while the value index slipped by 0.5%.</p>\n<p>“The market is flip-flopping between the view that economic growth has almost peaked so you need to buy stocks that manufacture their own growth like tech names, versus the view that economic growth will continue and you want to own cyclicals and value names,” said David Carter, chief investment officer at Lenox Wealth Advisors in New York.</p>\n<p>The number of U.S. workers filing first-time applications for unemployment benefits spiked unexpectedly to 419,000 last week, a two-month high, according to the Labor Department.</p>\n<p>Market participants are closely watching labor market indicators for hints as to when the Federal Reserve, expected to convene next week for its two-day monetary policy meeting, will begin discussions about hiking key interest rates from near zero.</p>\n<p>“The jobless data today didn’t have a meaningful impact on markets or the economic outlook,” Carter added. “It’s now all about how much longer the Fed will tolerate low rates. The Fed seems to be favoring its full employment mandate more than its price stability mandate.”</p>\n<p>“Accordingly, the upcoming Fed meeting could be impactful,” Carter said.</p>\n<p>Benchmark Treasury yields eased after the bid at the largest-ever TIPS auction touched a record low, pressuring rate sensitive banks.</p>\n<p>The Dow Jones Industrial Average rose 25.35 points, or 0.07%, to 34,823.35, the S&amp;P 500 gained 8.79 points, or 0.20%, to 4,367.48 and the Nasdaq Composite added 52.64 points, or 0.36%, to 14,684.60.</p>\n<p>Of the 11 major sectors of the S&amp;P 500, tech was shining brightest, gaining 0.7%. Energy stocks suffered the largest percentage drop.</p>\n<p>The second-quarter reporting season barreled ahead at full-throttle, with 104 of the companies in the S&amp;P 500 having reported. Of those, 88% have beaten consensus estimates, according to Refinitiv.</p>\n<p>Drugmaker Biogen Inc gained 1.1% after hiking its full-year revenue guidance, while Domino’s Pizza Inc surged 14.6% to an all-time high on the heels of its quarterly report.</p>\n<p>Southwest Airlines Co posted a bigger-than-expected quarterly loss, sending its stock down 3.5%, and American Airlines Group Inc dipped 1.1% even after reporting a quarterly profit.</p>\n<p>The S&amp;P 1500 Airlines index ended the session off 1.7%.</p>\n<p>Shares of Texas Instruments Inc slid 5.3% after its current-quarter revenue forecast cast concerns as to whether the company will be able to meet spiking demand in the face of a global semiconductor shortage.</p>\n<p>The Philadelphia SE Semiconductor index ended the session down 0.9%.</p>\n<p>Chipmaker Intel Corp slipped more than 1% in extended trading after the chipmaker posted results and raised its annual revenue forecast.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.82-to-1 ratio; on Nasdaq, a 1.90-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 39 new 52-week highs and no new lows; the Nasdaq Composite recorded 70 new highs and 54 new lows.</p>\n<p>Volume on U.S. exchanges was 8.25 billion shares, compared with the 10.12 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ekes out gains, led by tech, growth stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ekes out gains, led by tech, growth stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 07:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/usa-stocks/us-stocks-wall-street-ekes-out-gains-led-by-tech-growth-stocks-idUSL1N2OY2HH><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (Reuters) - Big tech helped Wall Street inch up to a higher close on Thursday, modestly building on a two-day rally as lackluster economic data and mixed corporate earnings prompted a pivot ...</p>\n\n<a href=\"https://www.reuters.com/article/usa-stocks/us-stocks-wall-street-ekes-out-gains-led-by-tech-growth-stocks-idUSL1N2OY2HH\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.reuters.com/article/usa-stocks/us-stocks-wall-street-ekes-out-gains-led-by-tech-growth-stocks-idUSL1N2OY2HH","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164478982","content_text":"NEW YORK (Reuters) - Big tech helped Wall Street inch up to a higher close on Thursday, modestly building on a two-day rally as lackluster economic data and mixed corporate earnings prompted a pivot back to growth stocks.\nA pull-back in economically sensitive cyclicals kept the S&P 500’s and the blue-chip Dow’s gains muted, while small-caps underperformed their larger rivals.\nBut megacap tech and tech-adjacent stocks, such as Microsoft Corp, Amazon.com, Apple Inc, Facebook Inc and Alphabet Inc, rose ahead of their quarterly results next week, putting the Nasdaq out front.\nAll three major U.S. stock indexes ended the session within 1% of their record closing highs.\nGrowth stocks, which outperformed throughout the health crisis, were back in favor, gaining 0.8%, while the value index slipped by 0.5%.\n“The market is flip-flopping between the view that economic growth has almost peaked so you need to buy stocks that manufacture their own growth like tech names, versus the view that economic growth will continue and you want to own cyclicals and value names,” said David Carter, chief investment officer at Lenox Wealth Advisors in New York.\nThe number of U.S. workers filing first-time applications for unemployment benefits spiked unexpectedly to 419,000 last week, a two-month high, according to the Labor Department.\nMarket participants are closely watching labor market indicators for hints as to when the Federal Reserve, expected to convene next week for its two-day monetary policy meeting, will begin discussions about hiking key interest rates from near zero.\n“The jobless data today didn’t have a meaningful impact on markets or the economic outlook,” Carter added. “It’s now all about how much longer the Fed will tolerate low rates. The Fed seems to be favoring its full employment mandate more than its price stability mandate.”\n“Accordingly, the upcoming Fed meeting could be impactful,” Carter said.\nBenchmark Treasury yields eased after the bid at the largest-ever TIPS auction touched a record low, pressuring rate sensitive banks.\nThe Dow Jones Industrial Average rose 25.35 points, or 0.07%, to 34,823.35, the S&P 500 gained 8.79 points, or 0.20%, to 4,367.48 and the Nasdaq Composite added 52.64 points, or 0.36%, to 14,684.60.\nOf the 11 major sectors of the S&P 500, tech was shining brightest, gaining 0.7%. Energy stocks suffered the largest percentage drop.\nThe second-quarter reporting season barreled ahead at full-throttle, with 104 of the companies in the S&P 500 having reported. Of those, 88% have beaten consensus estimates, according to Refinitiv.\nDrugmaker Biogen Inc gained 1.1% after hiking its full-year revenue guidance, while Domino’s Pizza Inc surged 14.6% to an all-time high on the heels of its quarterly report.\nSouthwest Airlines Co posted a bigger-than-expected quarterly loss, sending its stock down 3.5%, and American Airlines Group Inc dipped 1.1% even after reporting a quarterly profit.\nThe S&P 1500 Airlines index ended the session off 1.7%.\nShares of Texas Instruments Inc slid 5.3% after its current-quarter revenue forecast cast concerns as to whether the company will be able to meet spiking demand in the face of a global semiconductor shortage.\nThe Philadelphia SE Semiconductor index ended the session down 0.9%.\nChipmaker Intel Corp slipped more than 1% in extended trading after the chipmaker posted results and raised its annual revenue forecast.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.82-to-1 ratio; on Nasdaq, a 1.90-to-1 ratio favored decliners.\nThe S&P 500 posted 39 new 52-week highs and no new lows; the Nasdaq Composite recorded 70 new highs and 54 new lows.\nVolume on U.S. exchanges was 8.25 billion shares, compared with the 10.12 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":551,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835537670,"gmtCreate":1629726539390,"gmtModify":1676530112878,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"So share price is going up","listText":"So share price is going up","text":"So share price is going up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/835537670","repostId":"1189910879","repostType":4,"isVote":1,"tweetType":1,"viewCount":561,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":376889405,"gmtCreate":1619102435207,"gmtModify":1704719724140,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Is top glove going up?","listText":"Is top glove going up?","text":"Is top glove going up?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/376889405","repostId":"1150823744","repostType":4,"repost":{"id":"1150823744","kind":"news","pubTimestamp":1619101685,"share":"https://ttm.financial/m/news/1150823744?lang=&edition=fundamental","pubTime":"2021-04-22 22:28","market":"us","language":"en","title":"Top Glove Slashes Size of Hong Kong Share Sale to $1 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1150823744","media":"Bloomberg","summary":"Top Glove Corp., the world’s largest rubber glove maker, cut the size of its share sale in Hong Kong","content":"<p>Top Glove Corp., the world’s largest rubber glove maker, cut the size of its share sale in Hong Kong by nearly half of its earlier target.</p>\n<p>The company, whose shares are traded in Kuala Lumpur and Singapore, will issueup to793.5 million shares, down from 1.49 billion announced in February, it said in a filing on Thursday. The fundraising target stands reduced to 4.22 billion ringgit ($1 billion) from 7.77 billion ringgit previously, according to the filing.</p>\n<p>The revision comes despite the resurgence in Covid cases in some parts of the world that’s improved the outlook for producers of medical gloves. Top Glove’s shares are up 24% this month and were among the top gainers on Malaysia’s main index on Thursday along with peers Supermax Corp. and Hartalega Holdings Bhd.</p>\n<p>Top Glove, which is seeking a listing in Hong Kong to bolster its profile with overseas investors, was one of Asia’s hottest pandemic trades for 2020 before the rollouts of vaccines around the world dimmed their appeal.</p>\n<p>Pressure on the company deepened in late March when the U.S. Customs and Border Protection ordered personnel at U.S. ports of entry to seize gloves made in Malaysia over allegations of forced labor. Top Glove earlier this month said it is&nbsp;working&nbsp;with the U.S. authorities to resolve the issues to help lift the ban.</p>\n<p>Top Glove in February said the&nbsp;Hong Kong&nbsp;exchange listing will allow direct participation by new private and institutional investors in North Asia. The reduction in the issuance will minimize dilution to existing shareholders, according to the filing Thursday.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Glove Slashes Size of Hong Kong Share Sale to $1 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Glove Slashes Size of Hong Kong Share Sale to $1 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-22 22:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-04-22/top-glove-slashes-size-of-hong-kong-share-sale-to-1-billion?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top Glove Corp., the world’s largest rubber glove maker, cut the size of its share sale in Hong Kong by nearly half of its earlier target.\nThe company, whose shares are traded in Kuala Lumpur and ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-04-22/top-glove-slashes-size-of-hong-kong-share-sale-to-1-billion?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TGLVY":"Top Glove Corp.","TPGVF":"Top Glove Corp.","BVA.SI":"顶级手套有限公司"},"source_url":"https://www.bloomberg.com/news/articles/2021-04-22/top-glove-slashes-size-of-hong-kong-share-sale-to-1-billion?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150823744","content_text":"Top Glove Corp., the world’s largest rubber glove maker, cut the size of its share sale in Hong Kong by nearly half of its earlier target.\nThe company, whose shares are traded in Kuala Lumpur and Singapore, will issueup to793.5 million shares, down from 1.49 billion announced in February, it said in a filing on Thursday. The fundraising target stands reduced to 4.22 billion ringgit ($1 billion) from 7.77 billion ringgit previously, according to the filing.\nThe revision comes despite the resurgence in Covid cases in some parts of the world that’s improved the outlook for producers of medical gloves. Top Glove’s shares are up 24% this month and were among the top gainers on Malaysia’s main index on Thursday along with peers Supermax Corp. and Hartalega Holdings Bhd.\nTop Glove, which is seeking a listing in Hong Kong to bolster its profile with overseas investors, was one of Asia’s hottest pandemic trades for 2020 before the rollouts of vaccines around the world dimmed their appeal.\nPressure on the company deepened in late March when the U.S. Customs and Border Protection ordered personnel at U.S. ports of entry to seize gloves made in Malaysia over allegations of forced labor. Top Glove earlier this month said it is working with the U.S. authorities to resolve the issues to help lift the ban.\nTop Glove in February said the Hong Kong exchange listing will allow direct participation by new private and institutional investors in North Asia. The reduction in the issuance will minimize dilution to existing shareholders, according to the filing Thursday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815224635,"gmtCreate":1630682163527,"gmtModify":1676530376287,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Wow. I miss the boat again","listText":"Wow. I miss the boat again","text":"Wow. I miss the boat again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/815224635","repostId":"1105876391","repostType":4,"isVote":1,"tweetType":1,"viewCount":706,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":153186048,"gmtCreate":1625013621284,"gmtModify":1703850040995,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/153186048","repostId":"2147898672","repostType":4,"repost":{"id":"2147898672","kind":"news","pubTimestamp":1625013017,"share":"https://ttm.financial/m/news/2147898672?lang=&edition=fundamental","pubTime":"2021-06-30 08:30","market":"us","language":"en","title":"L Brand's Victoria's Secret Seeks To Raise $500M Via Private Debt Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2147898672","media":"Benzinga","summary":"$L Brands Inc$  has announced its subsidiary, Victoria’s Secret & Co, is offering to sell $500 million in aggregate principal amount of senior unsecured notes due 2029 in a private offering.Victoria’s Secret will use the proceeds from the Notes offering, after deducting discounts and commissions to the initial purchasers of the Notes and estimated offering expenses, to fund a portion of a cash payment to L Brands.Pending completion of the Separation proceeds from the offering of the Notes will b","content":"<ul>\n <li><b><a href=\"https://laohu8.com/S/LB\">L Brands Inc</a>&nbsp;</b>(NYSE: LB)&nbsp;has announced&nbsp;its subsidiary, Victoria’s Secret &amp; Co, is offering to sell $500 million in aggregate principal amount of senior unsecured notes due 2029 in a private offering.</li>\n <li>Victoria’s Secret will use the proceeds from the Notes offering, after deducting discounts and commissions to the initial purchasers of the Notes and estimated offering expenses, to fund a portion of a cash payment to L Brands.</li>\n <li>Pending completion of the Separation proceeds from the offering of the Notes will be deposited into escrow to benefit the holders of the Notes.</li>\n <li>America’s biggest lingerie retailer is preparing to become a standalone company, Victoria’s Secret &amp; Co, spun off from parent L Brands.</li>\n <li>L Brands’ cash and equivalents totaled $2.8 billion as of April 30, 2021.</li>\n <li><b>Price action:</b>&nbsp;LB shares closed higher by 0.34% at $71.21 on Tuesday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>L Brand's Victoria's Secret Seeks To Raise $500M Via Private Debt Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nL Brand's Victoria's Secret Seeks To Raise $500M Via Private Debt Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 08:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/l-brands-victorias-secret-seeks-203417230.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>L Brands Inc (NYSE: LB) has announced its subsidiary, Victoria’s Secret & Co, is offering to sell $500 million in aggregate principal amount of senior unsecured notes due 2029 in a private offering.\n...</p>\n\n<a href=\"https://finance.yahoo.com/news/l-brands-victorias-secret-seeks-203417230.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LB":"LandBridge Co. LLC"},"source_url":"https://finance.yahoo.com/news/l-brands-victorias-secret-seeks-203417230.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2147898672","content_text":"L Brands Inc (NYSE: LB) has announced its subsidiary, Victoria’s Secret & Co, is offering to sell $500 million in aggregate principal amount of senior unsecured notes due 2029 in a private offering.\nVictoria’s Secret will use the proceeds from the Notes offering, after deducting discounts and commissions to the initial purchasers of the Notes and estimated offering expenses, to fund a portion of a cash payment to L Brands.\nPending completion of the Separation proceeds from the offering of the Notes will be deposited into escrow to benefit the holders of the Notes.\nAmerica’s biggest lingerie retailer is preparing to become a standalone company, Victoria’s Secret & Co, spun off from parent L Brands.\nL Brands’ cash and equivalents totaled $2.8 billion as of April 30, 2021.\nPrice action: LB shares closed higher by 0.34% at $71.21 on Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":372978633,"gmtCreate":1619172864122,"gmtModify":1704720758726,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Hopefully we have a pm soon.","listText":"Hopefully we have a pm soon.","text":"Hopefully we have a pm soon.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/372978633","repostId":"1143062408","repostType":4,"repost":{"id":"1143062408","kind":"news","pubTimestamp":1619162341,"share":"https://ttm.financial/m/news/1143062408?lang=&edition=fundamental","pubTime":"2021-04-23 15:19","market":"sg","language":"en","title":"Singapore Names Wong as New Finance Minister in Cabinet Shake-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1143062408","media":"Bloomberg","summary":"Lawrence Wong was named Singapore’s next finance minister in a cabinetreshuffleFriday, boosting his ","content":"<p>Lawrence Wong was named Singapore’s next finance minister in a cabinetreshuffleFriday, boosting his prominence as the city-state reboots its leadership transition plan.</p>\n<p>The appointment follows Deputy Prime Minister Heng Swee Keat’s surprise announcement about two weeks ago that he’sstepping asideas the designated successor to Prime Minister Lee Hsien Loong within the People’s Action Party, which has led the country since independence. That forced changes to the long-telegraphed transition, leaving the party to seek a successor among its younger leaders before the next election due by 2025.</p>\n<p>Since founding father Lee Kuan Yew relinquished power some three decades ago, Singapore’s politics have been so well choreographed and predictable that they’re often joked about as dull. Local markets barely budged on Heng’s announcement earlier this month that he was stepping out of the running. Analysts have said they expect Singapore to remain politically stable.</p>\n<p>Though no clear successor to Lee was identified Friday, the finance minister selection could be a signal of who among the party’s “fourth-generation” leaders ultimately might be positioned for the top job. Heng was named finance chief in 2015 and added the&nbsp;deputy prime minister role&nbsp;to his portfolio in 2019. Lee himself was also finance minister previously, though his predecessor Goh Chok Tong didn’t hold that role.</p>\n<p><b>Covid Leadership</b></p>\n<p>Wong, 48, has seen his profile rise as co-chair of the government task force for fighting Covid-19. His role as second minister for finance provided a smooth path to the ministry’s top job.</p>\n<p>“Lawrence has been assisting Swee Keat as Second Minister since 2016, so he has the experience, and is a natural fit for the job,” Prime Minister Lee said at a briefing Friday.</p>\n<p>Known for a no-nonsense speaking manner, Wong played a critical role in helping to bring the pandemic under control in Singapore, with measures such as mandatory mask-wearing and strict social gathering rules.</p>\n<p>Before his appointment as minister of education and second minister of finance after last year’s election, he also oversaw a closely-watched property sector as minister for national development.</p>\n<p>Wong began his career as a civil servant, later serving as chief executive of the&nbsp;Energy Market Authority&nbsp;and as principal private secretary to Lee.</p>\n<p>Here are other changes to the cabinet, with the appointments taking effect on May 15, according to a statement:</p>\n<ul>\n <li>Gan Kim Yong will be trade and industry minister</li>\n <li>S. Iswaran will be transport minister</li>\n <li>Chan Chun Sing will be education minister</li>\n <li>Ong Ye Kung will be health minister</li>\n <li>Josephine Teo will be communications and information minister, and continue as second minister for home affairs</li>\n <li>Tan See Leng will be manpower minister</li>\n</ul>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Names Wong as New Finance Minister in Cabinet Shake-Up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Names Wong as New Finance Minister in Cabinet Shake-Up\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-23 15:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-04-23/singapore-names-wong-finance-minister-in-cabinet-shake-up-cna?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Lawrence Wong was named Singapore’s next finance minister in a cabinetreshuffleFriday, boosting his prominence as the city-state reboots its leadership transition plan.\nThe appointment follows Deputy ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-04-23/singapore-names-wong-finance-minister-in-cabinet-shake-up-cna?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.bloomberg.com/news/articles/2021-04-23/singapore-names-wong-finance-minister-in-cabinet-shake-up-cna?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143062408","content_text":"Lawrence Wong was named Singapore’s next finance minister in a cabinetreshuffleFriday, boosting his prominence as the city-state reboots its leadership transition plan.\nThe appointment follows Deputy Prime Minister Heng Swee Keat’s surprise announcement about two weeks ago that he’sstepping asideas the designated successor to Prime Minister Lee Hsien Loong within the People’s Action Party, which has led the country since independence. That forced changes to the long-telegraphed transition, leaving the party to seek a successor among its younger leaders before the next election due by 2025.\nSince founding father Lee Kuan Yew relinquished power some three decades ago, Singapore’s politics have been so well choreographed and predictable that they’re often joked about as dull. Local markets barely budged on Heng’s announcement earlier this month that he was stepping out of the running. Analysts have said they expect Singapore to remain politically stable.\nThough no clear successor to Lee was identified Friday, the finance minister selection could be a signal of who among the party’s “fourth-generation” leaders ultimately might be positioned for the top job. Heng was named finance chief in 2015 and added the deputy prime minister role to his portfolio in 2019. Lee himself was also finance minister previously, though his predecessor Goh Chok Tong didn’t hold that role.\nCovid Leadership\nWong, 48, has seen his profile rise as co-chair of the government task force for fighting Covid-19. His role as second minister for finance provided a smooth path to the ministry’s top job.\n“Lawrence has been assisting Swee Keat as Second Minister since 2016, so he has the experience, and is a natural fit for the job,” Prime Minister Lee said at a briefing Friday.\nKnown for a no-nonsense speaking manner, Wong played a critical role in helping to bring the pandemic under control in Singapore, with measures such as mandatory mask-wearing and strict social gathering rules.\nBefore his appointment as minister of education and second minister of finance after last year’s election, he also oversaw a closely-watched property sector as minister for national development.\nWong began his career as a civil servant, later serving as chief executive of the Energy Market Authority and as principal private secretary to Lee.\nHere are other changes to the cabinet, with the appointments taking effect on May 15, according to a statement:\n\nGan Kim Yong will be trade and industry minister\nS. Iswaran will be transport minister\nChan Chun Sing will be education minister\nOng Ye Kung will be health minister\nJosephine Teo will be communications and information minister, and continue as second minister for home affairs\nTan See Leng will be manpower minister","news_type":1},"isVote":1,"tweetType":1,"viewCount":177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345489933,"gmtCreate":1618329589822,"gmtModify":1704709323687,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Is it good to invest","listText":"Is it good to invest","text":"Is it good to invest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/345489933","repostId":"1194635432","repostType":4,"repost":{"id":"1194635432","kind":"news","pubTimestamp":1618236146,"share":"https://ttm.financial/m/news/1194635432?lang=&edition=fundamental","pubTime":"2021-04-12 22:02","market":"us","language":"en","title":"Can You Make Coin Investing In Coinbase?","url":"https://stock-news.laohu8.com/highlight/detail?id=1194635432","media":"seekingalpha","summary":"SummaryCoinbase's current valuation is unjustified due to 2 fundamental risks: the hostility of the ","content":"<p><b>Summary</b></p><ul><li>Coinbase's current valuation is unjustified due to 2 fundamental risks: the hostility of the US regulatory landscape towards centralized exchanges, and the widening gap in a winner-takes-all market.</li><li>With coin listings being one of the core competitive advantages of an exchange, Coinbase has the 2nd smallest coin listings among the top 10 exchanges as a result of regulations.</li><li>Widening gap between Coinbase (ranked 2nd) and Binance (ranked 1st) in terms of coin listings and trading volume is evidence of a winner-takes-all market, Coinbase is on the losing side.</li><li>Marginal revenue growth, decline in profitability, and decline in the overall growth stock valuations further plague Coinbase's investment value proposition.</li></ul><p>I remember the early days of cryptocurrency when Binance andCoinbase (COIN) were competing for the top spot as an exchange. If you've traded cryptocurrencies in the US, you have probably used or heard ofCoinbase. Now thatCoinbase is going public, should you invest in the company?</p><p>At first glance, this investment value proposition seemed compelling since the overall cryptocurrency industry is growing rapidly. However, I have found evidence of 2 fundamental risks toCoinbase's growth that could not justify its current valuation and could even undermine its future growth. Recentreportsmay also express agreement asCoinbase's IPO valuation dropped from $100bn to $68bn.</p><p><b>Fundamental Risks 1: The US Regulatory Landscape</b></p><p>The US regulatory landscape is not friendly to centralized exchanges in a way that massively dampenedCoinbase's competitive advantages, one of which is coin listings.</p><p>Coinbase has the 2nd smallest coin listings</p><p>Coin listing is one of the most crucial criteria for a trader/investor when choosing an exchange. Traders/investors require a large number of coin listings to speculate on small-cap altcoins for 10x-100x return. The more coins listed, the more opportunities and choices. I personally use several exchanges for this very reason other than unique features such as staking and etc. The 6 exchanges I use are Binance, Crypto.com, KuCoin, Bkex, PoloniEx, and MXC Pro.</p><p>Why do I use multiple exchanges? Let me illustrate via an example. KuCoin listed Orion(NYSE:ORN)in July 2020 at $1, about 2 months earlier than Binance in October 2020. I bought ORN through KuCoin on its first day at $1.1 and staked it at &gt;20% APY interest. When Binance announced it was listing ORN, its priced spiked upwards. On ORN's first trading day on Binance, ORN's price spiked up as high as $4++ (it is a common occurrence for a token to spike when it is listed in a new exchange). I redeemed my ORN from staking and sold it at $3.60. This transaction earned me more than 300% return. Therefore, the more coins listed, the more opportunities I'll have to replicate this particular transaction to other small-cap altcoins.</p><p>SinceCoinbase's coin listing is small, traders/investors like myself will find it difficult to find these kinds of opportunities. Furthermore, many of the largest-cap coins are not listed onCoinbase. This is one of the main reasons why I did not useCoinbase; I theorize that many traders/investors like myself feel that way. (Let me know in the comments.)</p><p>In a recent lawsuit, a man claiming to beCoinbase's client capitalized on the legal battle between Ripple Labs’ battle and U.S. Securities and Exchange Commission (SEC), suedCoinbase for selling XRP tokens and sought compensations and other relief. According to CoinMarketCap.com, XRP is no longer listed onCoinbase. However, it is listed on more than500 other centralized exchanges(excluding decentralized exchanges) that are much smaller thanCoinbase outside the US.</p><p>XRP is the 7th biggest cryptocurrency by market cap as of the time of writing. Many other top cryptocurrencies are also not found onCoinbase, such as BNB (ranked 3rd), ADA (ranked 4th), DOT (ranked 6th). Amongthe 10 highest-rated centralized exchanges(refer to Table 1), only Bitstamp (18) offers fewer cryptocurrencies thanCoinbase (49), while the market leader (Binance) ledCoinbase by 700% in coin listings.</p><p>Since regulation can directly affect coin listings, a competitive advantage of an exchange,Coinbase already faces overwhelming challenges to compete on this front alone.</p><p>Table 1: Top 10 Spot Exchange Ranked by CoinMarketCap Ratings.</p><p><img src=\"https://static.tigerbbs.com/5bf68da62452a794c5daaa60ac989840\" tg-width=\"554\" tg-height=\"576\" referrerpolicy=\"no-referrer\">Source: Table created by Author fromCoinMarketCap</p><p><b>Other Regulatory Risks</b></p><p>Regulatory risks extend beyond coin listings and the US.Coinbase offers its services to52 countries. If any of the 52 countries ban crypto assets, its revenue would be adversely affected. It is not uncommon for centralized exchanges to relocate to another country due to regulations. While India isplotting a move to ban cryptocurrencies, many exchanges apply forlicenses to move out from India.</p><p>Statistically speaking, 108 exchangesshut downin 2020, compared to 81 in 2019. At least 3 are shut down by government(s) in 2020, and at least 2 in 2019.</p><p>Although it seems unlikely for the US to follow China's and India's footsteps to drastically ban crypto-assets now, regulatory risks remain major risks toCoinbase.</p><p><b>Fundamental Risk 2: Losing a Winner-Takes-All Market</b></p><p>There are 2 types of crypto exchanges: centralized and decentralized. Both have pros and cons. The best known centralized exchange is Binance, while the best known decentralized exchange is Uniswap. Although centralized exchanges may require a license by a governing body, decentralized exchanges might not, as decentralized exchanges can have avarying degree of centralized components. Both centralized and decentralized exchanges have their respective roles in the crypto ecosystem, hence I think that both are here to stay.</p><p>Many of the decentralized exchange source codes are open source (full listshere). In other words, virtually anyone can develop and host a decentralized exchange. This implies a shallow barrier to entry. Uniswap is the market leader in the decentralized exchange space. Itrecordedmore than $58bn volume in 2020, up 15,000% from 2019. Note that Uniswap wasfirst launchedin November 2018, compared toCoinbase in 2012.</p><p>On the other hand, Binance, the market leader in the centralized exchange space, recorded a total of$1.417 trillion spot trading volume in 2020, an increase of 36% from 2019. This figure does not even include other trading volumes, such as options, futures, margin, and other services, which amounted to $1.7 trillion, a 2800% increase from 2019.</p><p>In comparison,Coinbase only recorded $445bn total trading volume in 2020, a 39% increase in 2019. This is evidence that the market leader is pulling away, implying a winner-takes-all market. This becomes evident by referring to Table 1, where the market leader has more than 10 times the trading value than the 2nd place (Coinbase).</p><p>Furthermore, many traditional financial, non-financial international corporations and fintech companies are also participating in the competition. One of the latest addition is ApplePay.ApplePaynow has official support for cryptocurrencies, with GooglePay and SamsungPay to follow suit. Other note-worthy companies include Square, Paypal, and Visa.</p><p>In my opinion,Coinbase looks to be on the losing side if this market is indeed a winner-takes-all market. Further,Coinbase could be losing market more market share as more competition arises.</p><p><img src=\"https://static.tigerbbs.com/01ca6dafd2b567bd920c5e9f8edc8fbb\" tg-width=\"640\" tg-height=\"202\" referrerpolicy=\"no-referrer\">Source:BusinessofApps</p><p><b>Valuation</b></p><p>The tables below showed thatCoinbase's profit margin is healthy at 28% in 2020. Revenue growth rate compounds at approximately 7% annually from 2017-2020, but profits declined.</p><p>Coinbase's valuation in 2017 remains the most attractive, at 1.725 P/S (Price-to-Sales ratio) and 4.21 P/E (Price-to-Earnings ratio). Earlier this month,Coinbase's IPO valuation is pegged at$100bn. However, recent reports indicated a decrease inCoinbase's IPO valuation to$68bn.At a valuation of $100bn and $68bn,Coinbase is valued at approximately 333 P/E and 211 P/E respectively, or approximately 87.7 P/S and 59.65 P/S respectively.</p><p>Coinbase's valuation in 2020 is a far cry from 2017. Perhaps,Coinbase is pushing for its IPO to cash in on the overall stock market's high valuation.</p><p>Nevertheless, considering the 2 fundamental risks outlined above, marginal revenue growth and declined profits,Coinbase is overvalued at the current valuation in my opinion. The current decline in growth stocks further deterioratesCoinbase's investment value proposition.</p><p>Table 3:Coinbase's Revenue from 2016-2020<img src=\"https://static.tigerbbs.com/de8396c363230e04130e43f63d653956\" tg-width=\"640\" tg-height=\"231\" referrerpolicy=\"no-referrer\">Source:BusinessofApps</p><p>Table 4:Coinbase's Profit from 2016-2020<img src=\"https://static.tigerbbs.com/be2327ad800bd3524a3aaa57e3a0b17f\" tg-width=\"640\" tg-height=\"208\" referrerpolicy=\"no-referrer\">Source:BusinessofApps</p><p>Table 5:Coinbase's Historical Valuations<img src=\"https://static.tigerbbs.com/4b1fd86395ee1b0e38f1f6fd472f84bd\" tg-width=\"640\" tg-height=\"159\" referrerpolicy=\"no-referrer\">Source:BusinessofApps</p><p><b>Verdict</b></p><p>In my opinion, the current valuation ofCoinbase couldn't be justified even though the crypto industry is growing rapidly in general. This is down toCoinbase's 2 fundamental risks outlined in this article, marginal growth, sky-high valuation, and the decline in the growth stocks.</p><p>The reason I retain a neutral outlook onCoinbase is the overall outlook of the industry. On the other hand, we can participate in Binance, the market leader in the centralized exchange space, to maximize investment growth. Although Binance is not publicly traded, we can participate in its growth by buying its platform token (BNB).Binance uses part of its profitsto buy back its platform token (BNB)periodically. This results in a gradual increase in its token's price, a similar effect of shares buyback. Hence, I participate in Binance's growth by buying BNB, which saw a 670% YTD return.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can You Make Coin Investing In Coinbase?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan You Make Coin Investing In Coinbase?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-12 22:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4416527-coinbase-path-to-moon-will-be-bumpy-one><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryCoinbase's current valuation is unjustified due to 2 fundamental risks: the hostility of the US regulatory landscape towards centralized exchanges, and the widening gap in a winner-takes-all ...</p>\n\n<a href=\"https://seekingalpha.com/article/4416527-coinbase-path-to-moon-will-be-bumpy-one\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COIN":"Coinbase Global, Inc."},"source_url":"https://seekingalpha.com/article/4416527-coinbase-path-to-moon-will-be-bumpy-one","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1194635432","content_text":"SummaryCoinbase's current valuation is unjustified due to 2 fundamental risks: the hostility of the US regulatory landscape towards centralized exchanges, and the widening gap in a winner-takes-all market.With coin listings being one of the core competitive advantages of an exchange, Coinbase has the 2nd smallest coin listings among the top 10 exchanges as a result of regulations.Widening gap between Coinbase (ranked 2nd) and Binance (ranked 1st) in terms of coin listings and trading volume is evidence of a winner-takes-all market, Coinbase is on the losing side.Marginal revenue growth, decline in profitability, and decline in the overall growth stock valuations further plague Coinbase's investment value proposition.I remember the early days of cryptocurrency when Binance andCoinbase (COIN) were competing for the top spot as an exchange. If you've traded cryptocurrencies in the US, you have probably used or heard ofCoinbase. Now thatCoinbase is going public, should you invest in the company?At first glance, this investment value proposition seemed compelling since the overall cryptocurrency industry is growing rapidly. However, I have found evidence of 2 fundamental risks toCoinbase's growth that could not justify its current valuation and could even undermine its future growth. Recentreportsmay also express agreement asCoinbase's IPO valuation dropped from $100bn to $68bn.Fundamental Risks 1: The US Regulatory LandscapeThe US regulatory landscape is not friendly to centralized exchanges in a way that massively dampenedCoinbase's competitive advantages, one of which is coin listings.Coinbase has the 2nd smallest coin listingsCoin listing is one of the most crucial criteria for a trader/investor when choosing an exchange. Traders/investors require a large number of coin listings to speculate on small-cap altcoins for 10x-100x return. The more coins listed, the more opportunities and choices. I personally use several exchanges for this very reason other than unique features such as staking and etc. The 6 exchanges I use are Binance, Crypto.com, KuCoin, Bkex, PoloniEx, and MXC Pro.Why do I use multiple exchanges? Let me illustrate via an example. KuCoin listed Orion(NYSE:ORN)in July 2020 at $1, about 2 months earlier than Binance in October 2020. I bought ORN through KuCoin on its first day at $1.1 and staked it at >20% APY interest. When Binance announced it was listing ORN, its priced spiked upwards. On ORN's first trading day on Binance, ORN's price spiked up as high as $4++ (it is a common occurrence for a token to spike when it is listed in a new exchange). I redeemed my ORN from staking and sold it at $3.60. This transaction earned me more than 300% return. Therefore, the more coins listed, the more opportunities I'll have to replicate this particular transaction to other small-cap altcoins.SinceCoinbase's coin listing is small, traders/investors like myself will find it difficult to find these kinds of opportunities. Furthermore, many of the largest-cap coins are not listed onCoinbase. This is one of the main reasons why I did not useCoinbase; I theorize that many traders/investors like myself feel that way. (Let me know in the comments.)In a recent lawsuit, a man claiming to beCoinbase's client capitalized on the legal battle between Ripple Labs’ battle and U.S. Securities and Exchange Commission (SEC), suedCoinbase for selling XRP tokens and sought compensations and other relief. According to CoinMarketCap.com, XRP is no longer listed onCoinbase. However, it is listed on more than500 other centralized exchanges(excluding decentralized exchanges) that are much smaller thanCoinbase outside the US.XRP is the 7th biggest cryptocurrency by market cap as of the time of writing. Many other top cryptocurrencies are also not found onCoinbase, such as BNB (ranked 3rd), ADA (ranked 4th), DOT (ranked 6th). Amongthe 10 highest-rated centralized exchanges(refer to Table 1), only Bitstamp (18) offers fewer cryptocurrencies thanCoinbase (49), while the market leader (Binance) ledCoinbase by 700% in coin listings.Since regulation can directly affect coin listings, a competitive advantage of an exchange,Coinbase already faces overwhelming challenges to compete on this front alone.Table 1: Top 10 Spot Exchange Ranked by CoinMarketCap Ratings.Source: Table created by Author fromCoinMarketCapOther Regulatory RisksRegulatory risks extend beyond coin listings and the US.Coinbase offers its services to52 countries. If any of the 52 countries ban crypto assets, its revenue would be adversely affected. It is not uncommon for centralized exchanges to relocate to another country due to regulations. While India isplotting a move to ban cryptocurrencies, many exchanges apply forlicenses to move out from India.Statistically speaking, 108 exchangesshut downin 2020, compared to 81 in 2019. At least 3 are shut down by government(s) in 2020, and at least 2 in 2019.Although it seems unlikely for the US to follow China's and India's footsteps to drastically ban crypto-assets now, regulatory risks remain major risks toCoinbase.Fundamental Risk 2: Losing a Winner-Takes-All MarketThere are 2 types of crypto exchanges: centralized and decentralized. Both have pros and cons. The best known centralized exchange is Binance, while the best known decentralized exchange is Uniswap. Although centralized exchanges may require a license by a governing body, decentralized exchanges might not, as decentralized exchanges can have avarying degree of centralized components. Both centralized and decentralized exchanges have their respective roles in the crypto ecosystem, hence I think that both are here to stay.Many of the decentralized exchange source codes are open source (full listshere). In other words, virtually anyone can develop and host a decentralized exchange. This implies a shallow barrier to entry. Uniswap is the market leader in the decentralized exchange space. Itrecordedmore than $58bn volume in 2020, up 15,000% from 2019. Note that Uniswap wasfirst launchedin November 2018, compared toCoinbase in 2012.On the other hand, Binance, the market leader in the centralized exchange space, recorded a total of$1.417 trillion spot trading volume in 2020, an increase of 36% from 2019. This figure does not even include other trading volumes, such as options, futures, margin, and other services, which amounted to $1.7 trillion, a 2800% increase from 2019.In comparison,Coinbase only recorded $445bn total trading volume in 2020, a 39% increase in 2019. This is evidence that the market leader is pulling away, implying a winner-takes-all market. This becomes evident by referring to Table 1, where the market leader has more than 10 times the trading value than the 2nd place (Coinbase).Furthermore, many traditional financial, non-financial international corporations and fintech companies are also participating in the competition. One of the latest addition is ApplePay.ApplePaynow has official support for cryptocurrencies, with GooglePay and SamsungPay to follow suit. Other note-worthy companies include Square, Paypal, and Visa.In my opinion,Coinbase looks to be on the losing side if this market is indeed a winner-takes-all market. Further,Coinbase could be losing market more market share as more competition arises.Source:BusinessofAppsValuationThe tables below showed thatCoinbase's profit margin is healthy at 28% in 2020. Revenue growth rate compounds at approximately 7% annually from 2017-2020, but profits declined.Coinbase's valuation in 2017 remains the most attractive, at 1.725 P/S (Price-to-Sales ratio) and 4.21 P/E (Price-to-Earnings ratio). Earlier this month,Coinbase's IPO valuation is pegged at$100bn. However, recent reports indicated a decrease inCoinbase's IPO valuation to$68bn.At a valuation of $100bn and $68bn,Coinbase is valued at approximately 333 P/E and 211 P/E respectively, or approximately 87.7 P/S and 59.65 P/S respectively.Coinbase's valuation in 2020 is a far cry from 2017. Perhaps,Coinbase is pushing for its IPO to cash in on the overall stock market's high valuation.Nevertheless, considering the 2 fundamental risks outlined above, marginal revenue growth and declined profits,Coinbase is overvalued at the current valuation in my opinion. The current decline in growth stocks further deterioratesCoinbase's investment value proposition.Table 3:Coinbase's Revenue from 2016-2020Source:BusinessofAppsTable 4:Coinbase's Profit from 2016-2020Source:BusinessofAppsTable 5:Coinbase's Historical ValuationsSource:BusinessofAppsVerdictIn my opinion, the current valuation ofCoinbase couldn't be justified even though the crypto industry is growing rapidly in general. This is down toCoinbase's 2 fundamental risks outlined in this article, marginal growth, sky-high valuation, and the decline in the growth stocks.The reason I retain a neutral outlook onCoinbase is the overall outlook of the industry. On the other hand, we can participate in Binance, the market leader in the centralized exchange space, to maximize investment growth. Although Binance is not publicly traded, we can participate in its growth by buying its platform token (BNB).Binance uses part of its profitsto buy back its platform token (BNB)periodically. This results in a gradual increase in its token's price, a similar effect of shares buyback. Hence, I participate in Binance's growth by buying BNB, which saw a 670% YTD return.","news_type":1},"isVote":1,"tweetType":1,"viewCount":76,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157660550,"gmtCreate":1625580558370,"gmtModify":1703744294705,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Hopping all go to the moon","listText":"Hopping all go to the moon","text":"Hopping all go to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157660550","repostId":"1118465420","repostType":4,"repost":{"id":"1118465420","kind":"news","pubTimestamp":1625580135,"share":"https://ttm.financial/m/news/1118465420?lang=&edition=fundamental","pubTime":"2021-07-06 22:02","market":"us","language":"en","title":"Advaxis Jumps on Deal to Be Bought by Biosight","url":"https://stock-news.laohu8.com/highlight/detail?id=1118465420","media":"Thestreet","summary":"Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Bi","content":"<p>Advaxis&nbsp;(<b>ADXS</b>)&nbsp;shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.</p>\n<p>At closing, Biosight holders will own 75%&nbsp;of the company and&nbsp;Advaxis holders will own 25%.</p>\n<p>Advaxis,&nbsp;Princeton, N.J.,&nbsp;recently traded at 70 cents a share, up 48%. It had gained 5% in the six months through Friday.</p>\n<p>The combined company will be named Biosight Therapeutics and trade on Nasdaq with the ticker symbol BSTX.</p>\n<p>“The proposed merger will create a public company that will prioritize the clinical advancement and commercialization of Biosight’s lead product, aspacytarabine,” the companies said. That drug treats acute myeloid leukemia.</p>\n<p>The new company is expected to have some $50 million cash, cash equivalents and marketable securities. The deal is expected to close in the second half, subject to conditions including regulatory clearances and votes of holders of both companies.</p>\n<p>In other healthcare news, Iterum Therapeutics&nbsp;(<b>ITRM</b>) -Get Report&nbsp;said Friday that it received a letterfrom the FDA saying that deficiencies in its treatment for urinary-tract infections&nbsp;were found.</p>\n<p>The Food and Drug Administration letter stated that as “part of their ongoing review of the company’s new drug application for sulopenem etzadroxil/probenecid, the agency has identified deficiencies that preclude the continuation of the discussion of labeling and post-marketing requirements/commitments at this time,” Iterum said.</p>\n<p>Also last week,Anavex Life Sciences&nbsp;(<b>AVXL</b>) -Get Report&nbsp;reported progress in a Phase 2 trial of a Parkinson’s drug, Anavex2-73.</p>\n<p>JonesTrading analyst Soumit Roy raised his price target on the New York company to $50 from $35, affirming a buy rating.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Advaxis Jumps on Deal to Be Bought by Biosight</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdvaxis Jumps on Deal to Be Bought by Biosight\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-06 22:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.\nAt closing, Biosight holders will own 75% of the company and ...</p>\n\n<a href=\"https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADXS":"Ayala Pharmaceuticals, Inc."},"source_url":"https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118465420","content_text":"Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.\nAt closing, Biosight holders will own 75% of the company and Advaxis holders will own 25%.\nAdvaxis, Princeton, N.J., recently traded at 70 cents a share, up 48%. It had gained 5% in the six months through Friday.\nThe combined company will be named Biosight Therapeutics and trade on Nasdaq with the ticker symbol BSTX.\n“The proposed merger will create a public company that will prioritize the clinical advancement and commercialization of Biosight’s lead product, aspacytarabine,” the companies said. That drug treats acute myeloid leukemia.\nThe new company is expected to have some $50 million cash, cash equivalents and marketable securities. The deal is expected to close in the second half, subject to conditions including regulatory clearances and votes of holders of both companies.\nIn other healthcare news, Iterum Therapeutics (ITRM) -Get Report said Friday that it received a letterfrom the FDA saying that deficiencies in its treatment for urinary-tract infections were found.\nThe Food and Drug Administration letter stated that as “part of their ongoing review of the company’s new drug application for sulopenem etzadroxil/probenecid, the agency has identified deficiencies that preclude the continuation of the discussion of labeling and post-marketing requirements/commitments at this time,” Iterum said.\nAlso last week,Anavex Life Sciences (AVXL) -Get Report reported progress in a Phase 2 trial of a Parkinson’s drug, Anavex2-73.\nJonesTrading analyst Soumit Roy raised his price target on the New York company to $50 from $35, affirming a buy rating.","news_type":1},"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345665743,"gmtCreate":1618310456282,"gmtModify":1704708932356,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Hopefully bank got higher","listText":"Hopefully bank got higher","text":"Hopefully bank got higher","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/345665743","repostId":"1102483578","repostType":4,"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":357257563,"gmtCreate":1617281382852,"gmtModify":1704698227433,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Will telsa hit 700 today?","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Will telsa hit 700 today?","text":"$Tesla Motors(TSLA)$Will telsa hit 700 today?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/357257563","isVote":1,"tweetType":1,"viewCount":779,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141843140,"gmtCreate":1625850319980,"gmtModify":1703749926061,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"AMC to the moon&nbsp;","listText":"AMC to the moon&nbsp;","text":"AMC to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141843140","repostId":"1173374462","repostType":4,"repost":{"id":"1173374462","kind":"news","pubTimestamp":1625840008,"share":"https://ttm.financial/m/news/1173374462?lang=&edition=fundamental","pubTime":"2021-07-09 22:13","market":"us","language":"en","title":"Meme Stocks Like GameStop and AMC Reflect Market Reality","url":"https://stock-news.laohu8.com/highlight/detail?id=1173374462","media":"Thestreet","summary":"Gamestop (GME) made some investors rich… and then it broke many more. Investing in AMC Entertainment","content":"<p>Gamestop&nbsp;(<b>GME</b>)&nbsp;made some investors rich… and then it broke many more. Investing in AMC Entertainment&nbsp;(<b>AMC</b>)&nbsp;did the exact same thing. These two stocks represent, if not failing businesses, at least ailing ones; companies that struggled to keep up with the new economy even before the pandemic shut down large swaths of it. Yet over the past few months they have posted some of the most volatile gains and losses on the market.</p>\n<p>How?</p>\n<p>It’s down to what Real Money's Timothy Collins calls the market of “meme stock hyperbole.” But, he writes, is it really all that different from how trading has always worked?</p>\n<p>Have you ever really thought about the phrases 'to the moon' or 'conviction buy,' and how they mess with out perception of fair value?</p>\n<p>\"Initially, I rolled my eyes at the continued use of the phrase 'To The Moon,'\" Collins says. \"It's not like 'Strong Buy with a price target of $65', for instance. 'To the moon' is completely arbitrary and open to interpretation, but then again so are most things about valuation, when you think about it,\" Collins wrote.</p>\n<p>\"For instance, when an analyst pounds the table on a stock, how is that different from 'to the moon?' Or when someone says, 'all in.' Are they really all in? Did they cash in all their assets, pool the liquidity, and buy every share they possibly could? Probably not. Actually, I'd say definitely not 99.9999% of the time. Of course, there's always that one person,\" Collins said.</p>\n<p>\"But the point isWall Street has been arbitraryfor years. We can't even have a standard rating system. Is it 'Neutral' or 'Hold?' And really, do I want to hold something that is only in the middle of your range? No.\"</p>\n<p>Collins writes, \"The system should be 'buy' or 'sell.' That's it. Black or white. Own or don't own.\"</p>\n<p>Assets like GameStop and even cryptocurrency seem to be selling on nothing more than pure emotion. Investors are taking these products for a joy ride, and that tends to send prices flying up and down the ladder.</p>\n<p>That’s confusing, to be sure. Just, before you go throwing your hands in the air, it’s important to remember that the stock market has always been at least a little bit arbitrary.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Meme Stocks Like GameStop and AMC Reflect Market Reality</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMeme Stocks Like GameStop and AMC Reflect Market Reality\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 22:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/meme-stocks-like-gamestop-amc-reflect-market-reality><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gamestop (GME) made some investors rich… and then it broke many more. Investing in AMC Entertainment (AMC) did the exact same thing. These two stocks represent, if not failing businesses, at least ...</p>\n\n<a href=\"https://www.thestreet.com/investing/meme-stocks-like-gamestop-amc-reflect-market-reality\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","GME":"游戏驿站"},"source_url":"https://www.thestreet.com/investing/meme-stocks-like-gamestop-amc-reflect-market-reality","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173374462","content_text":"Gamestop (GME) made some investors rich… and then it broke many more. Investing in AMC Entertainment (AMC) did the exact same thing. These two stocks represent, if not failing businesses, at least ailing ones; companies that struggled to keep up with the new economy even before the pandemic shut down large swaths of it. Yet over the past few months they have posted some of the most volatile gains and losses on the market.\nHow?\nIt’s down to what Real Money's Timothy Collins calls the market of “meme stock hyperbole.” But, he writes, is it really all that different from how trading has always worked?\nHave you ever really thought about the phrases 'to the moon' or 'conviction buy,' and how they mess with out perception of fair value?\n\"Initially, I rolled my eyes at the continued use of the phrase 'To The Moon,'\" Collins says. \"It's not like 'Strong Buy with a price target of $65', for instance. 'To the moon' is completely arbitrary and open to interpretation, but then again so are most things about valuation, when you think about it,\" Collins wrote.\n\"For instance, when an analyst pounds the table on a stock, how is that different from 'to the moon?' Or when someone says, 'all in.' Are they really all in? Did they cash in all their assets, pool the liquidity, and buy every share they possibly could? Probably not. Actually, I'd say definitely not 99.9999% of the time. Of course, there's always that one person,\" Collins said.\n\"But the point isWall Street has been arbitraryfor years. We can't even have a standard rating system. Is it 'Neutral' or 'Hold?' And really, do I want to hold something that is only in the middle of your range? No.\"\nCollins writes, \"The system should be 'buy' or 'sell.' That's it. Black or white. Own or don't own.\"\nAssets like GameStop and even cryptocurrency seem to be selling on nothing more than pure emotion. Investors are taking these products for a joy ride, and that tends to send prices flying up and down the ladder.\nThat’s confusing, to be sure. Just, before you go throwing your hands in the air, it’s important to remember that the stock market has always been at least a little bit arbitrary.","news_type":1},"isVote":1,"tweetType":1,"viewCount":286,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":105854636,"gmtCreate":1620292065625,"gmtModify":1704341435727,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>Hopefully the stock will move to Ath now","listText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>Hopefully the stock will move to Ath now","text":"$Luokung Technology Corp(LKCO)$Hopefully the stock will move to Ath now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/105854636","isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103571741,"gmtCreate":1619796641183,"gmtModify":1704272563996,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Test","listText":"Test","text":"Test","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/103571741","repostId":"1165708828","repostType":4,"repost":{"id":"1165708828","kind":"news","pubTimestamp":1619792862,"share":"https://ttm.financial/m/news/1165708828?lang=&edition=fundamental","pubTime":"2021-04-30 22:27","market":"us","language":"en","title":"3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1165708828","media":"Motley Fool","summary":"For more than a year, patient investors have been handsomely rewarded. All three of the market's maj","content":"<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.</p>\n<p>Yet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in the<b>S&amp;P 500</b>,<b>Dow Jones Industrial Average</b>, and<b>Nasdaq Composite</b>, this represents a huge underperformance.</p>\n<p>But according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.</p>\n<p>Sarepta Therapeutics: Implied upside of 91%</p>\n<p>Many of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developer<b>Sarepta Therapeutics</b>(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.</p>\n<p>Sarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.</p>\n<p>However, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.&nbsp; In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.</p>\n<p>The Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.</p>\n<p>Intercept Pharmaceuticals: Implied upside of 97%</p>\n<p>If you wanteven more upside potential, Wall Street would steer you toward small-cap<b>Intercept Pharmaceuticals</b>(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.</p>\n<p>Similar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.</p>\n<p>Intercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.</p>\n<p>On the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.</p>\n<p>If OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.</p>\n<p>It's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.</p>\n<p>Inovio Pharmaceuticals: Implied upside of 104%</p>\n<p>Yet another biotech stock withbig-time upside potential, according to Wall Street, is<b>Inovio Pharmaceuticals</b>(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.</p>\n<p>For much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.</p>\n<p>Unfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.</p>\n<p>There are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players like<b>Johnson &amp; Johnson</b>&nbsp;can produce up to 3 billion doses for the global market this year. As a reminder, J&amp;J's vaccine is a single-dose treatment.</p>\n<p>The other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.</p>\n<p>With a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 22:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165708828","content_text":"For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.\nYet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in theS&P 500,Dow Jones Industrial Average, andNasdaq Composite, this represents a huge underperformance.\nBut according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.\nSarepta Therapeutics: Implied upside of 91%\nMany of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developerSarepta Therapeutics(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.\nSarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.\nHowever, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.  In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.\nThe Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.\nIntercept Pharmaceuticals: Implied upside of 97%\nIf you wanteven more upside potential, Wall Street would steer you toward small-capIntercept Pharmaceuticals(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.\nSimilar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.\nIntercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.\nOn the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.\nIf OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.\nIt's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.\nInovio Pharmaceuticals: Implied upside of 104%\nYet another biotech stock withbig-time upside potential, according to Wall Street, isInovio Pharmaceuticals(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.\nFor much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.\nUnfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.\nThere are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players likeJohnson & Johnson can produce up to 3 billion doses for the global market this year. As a reminder, J&J's vaccine is a single-dose treatment.\nThe other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.\nWith a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.","news_type":1},"isVote":1,"tweetType":1,"viewCount":154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":100816025,"gmtCreate":1619598762967,"gmtModify":1704726567800,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Wow. Apple go go go&nbsp;","listText":"Wow. Apple go go go&nbsp;","text":"Wow. Apple go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/100816025","repostId":"1179396069","repostType":4,"repost":{"id":"1179396069","kind":"news","pubTimestamp":1619573853,"share":"https://ttm.financial/m/news/1179396069?lang=&edition=fundamental","pubTime":"2021-04-28 09:37","market":"us","language":"en","title":"Apple Could Blow the Top Off Earnings—Again. What That Would Mean for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1179396069","media":"Barrons","summary":"Apple has its work cut out for it trying to surpass 2020’s blowout results. The thing is, the tech g","content":"<p>Apple has its work cut out for it trying to surpass 2020’s blowout results. The thing is, the tech giant just might be able to pull it off.</p>\n<p>The buzz around Apple last year was off the charts, even for what is the buzziest of technology companies. Anticipation of the fall launch of the company’s first 5G phones, surging demand for both Macs and iPads as the pandemic rolled on, and strength in both wearables and services fed off each other. The pieces all came together in the December quarter, when Apple (ticker: AAPL) posted&nbsp;its biggest quarter ever. Sales soared 21% to $111.4 billion, more than $8 billion over the Street consensus. Every product category—iPhone, iPad, Macs, wearables, and services—notched double-digit growth. Apple stock finished the year up 81%, adding nearly $1 trillion to its market cap.</p>\n<p>That’s a tough act to follow, particularly with the March quarter, which always slows from the holiday-boosted December quarter. But Apple could pull off the quintuple double again when its results come out after the bell Wednesday. The Street certainly thinks so, even if the market, which has pushed Apple shares up less than 2% in 2021, has been more cautious. Consensus estimates call for double-digit increases from last year across the board: iPhones sales up 43%, to $41.4 billion; iPad sales up 29%, to $5.6 billion; Mac sales of $6.8 billion, up 27%; wearables sales (mostly Apple Watch and AirPods) of $7.4 billion, up 18%; and a 16% bump in services, to $15.5 billion.</p>\n<p>Overall, the Street consensus expects sales of $77 billion, up 32% from a year ago, with profits of 98 cents a share. That would be the fastest top-line growth rate for any Apple quarter since March 2012, when revenues were about half what they are now. And most bullish Apple analysts seem to think their own estimates are too low—a print at $77 billion would likely trigger a selloff in the stock.</p>\n<p>Apple is also&nbsp;expected to provide an update on its capital-allocation strategy. A year ago,the company announced a 6% dividend increase, and boosted its stock repurchase plan by $50 billion. Apple has said repeatedly that it is pushing to get to a cash neutral position, but its remarkably big cash flow has slowed progress toward that goal.</p>\n<p>As always, the quarter is about more than just earnings.</p>\n<p>For one, the Street will be looking for signs that the sales surge for Macs and iPads is sustainable—and that the company is keeping up with demand despite widespread chip and display shortages. Some investors worry that the spike in PC demand could ebb as more people return to schools and offices. They’ll be looking for company guidance on that point.</p>\n<p>Another is the sustainability of the resurgence in iPhone growth. There were high hopes among bulls that the iPhone 12 would drive a “supercycle” with an accelerated replacement cycle. Several analysts have noted that a clear consumer preference for the high end of the iPhone 12 line is driving up average selling prices, which should support a strong revenue quarter for the segment.</p>\n<p>“Given the later-than-seasonal launch of new iPhones in the fall of 2020, we believe iPhone demand will experience more favorable year-over-year comparisons this March quarter compared to past years,” writes Monness Crespi Hardt’s Brian White, who sees 47% iPhone revenue growth during the quarter.</p>\n<p>And if Apple pulls it all together? Apple could crush Street estimates, writes Morgan Stanley analyst Katy Huberty, who has an Overweight rating and a $158 price target on the stock, up 17% from Monday’s close of $134.72. She sees the top line above $80 billion, with all segments growing at least 19% year over year. She is especially bullish on Mac and iPad sales, with estimates far above consensus—53% for Macs and 52% for iPads. She also expects Apple to increase its dividend by 10% and expand its stock repurchase program by $60 billion.</p>\n<p>That would certainly qualify as a job well done.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Could Blow the Top Off Earnings—Again. What That Would Mean for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Could Blow the Top Off Earnings—Again. What That Would Mean for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-28 09:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/apple-could-blow-the-top-off-earningsagain-what-that-would-mean-for-the-stock-51619495288?mod=hp_DAY_Theme_1_2><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple has its work cut out for it trying to surpass 2020’s blowout results. The thing is, the tech giant just might be able to pull it off.\nThe buzz around Apple last year was off the charts, even for...</p>\n\n<a href=\"https://www.barrons.com/articles/apple-could-blow-the-top-off-earningsagain-what-that-would-mean-for-the-stock-51619495288?mod=hp_DAY_Theme_1_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.barrons.com/articles/apple-could-blow-the-top-off-earningsagain-what-that-would-mean-for-the-stock-51619495288?mod=hp_DAY_Theme_1_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179396069","content_text":"Apple has its work cut out for it trying to surpass 2020’s blowout results. The thing is, the tech giant just might be able to pull it off.\nThe buzz around Apple last year was off the charts, even for what is the buzziest of technology companies. Anticipation of the fall launch of the company’s first 5G phones, surging demand for both Macs and iPads as the pandemic rolled on, and strength in both wearables and services fed off each other. The pieces all came together in the December quarter, when Apple (ticker: AAPL) posted its biggest quarter ever. Sales soared 21% to $111.4 billion, more than $8 billion over the Street consensus. Every product category—iPhone, iPad, Macs, wearables, and services—notched double-digit growth. Apple stock finished the year up 81%, adding nearly $1 trillion to its market cap.\nThat’s a tough act to follow, particularly with the March quarter, which always slows from the holiday-boosted December quarter. But Apple could pull off the quintuple double again when its results come out after the bell Wednesday. The Street certainly thinks so, even if the market, which has pushed Apple shares up less than 2% in 2021, has been more cautious. Consensus estimates call for double-digit increases from last year across the board: iPhones sales up 43%, to $41.4 billion; iPad sales up 29%, to $5.6 billion; Mac sales of $6.8 billion, up 27%; wearables sales (mostly Apple Watch and AirPods) of $7.4 billion, up 18%; and a 16% bump in services, to $15.5 billion.\nOverall, the Street consensus expects sales of $77 billion, up 32% from a year ago, with profits of 98 cents a share. That would be the fastest top-line growth rate for any Apple quarter since March 2012, when revenues were about half what they are now. And most bullish Apple analysts seem to think their own estimates are too low—a print at $77 billion would likely trigger a selloff in the stock.\nApple is also expected to provide an update on its capital-allocation strategy. A year ago,the company announced a 6% dividend increase, and boosted its stock repurchase plan by $50 billion. Apple has said repeatedly that it is pushing to get to a cash neutral position, but its remarkably big cash flow has slowed progress toward that goal.\nAs always, the quarter is about more than just earnings.\nFor one, the Street will be looking for signs that the sales surge for Macs and iPads is sustainable—and that the company is keeping up with demand despite widespread chip and display shortages. Some investors worry that the spike in PC demand could ebb as more people return to schools and offices. They’ll be looking for company guidance on that point.\nAnother is the sustainability of the resurgence in iPhone growth. There were high hopes among bulls that the iPhone 12 would drive a “supercycle” with an accelerated replacement cycle. Several analysts have noted that a clear consumer preference for the high end of the iPhone 12 line is driving up average selling prices, which should support a strong revenue quarter for the segment.\n“Given the later-than-seasonal launch of new iPhones in the fall of 2020, we believe iPhone demand will experience more favorable year-over-year comparisons this March quarter compared to past years,” writes Monness Crespi Hardt’s Brian White, who sees 47% iPhone revenue growth during the quarter.\nAnd if Apple pulls it all together? Apple could crush Street estimates, writes Morgan Stanley analyst Katy Huberty, who has an Overweight rating and a $158 price target on the stock, up 17% from Monday’s close of $134.72. She sees the top line above $80 billion, with all segments growing at least 19% year over year. She is especially bullish on Mac and iPad sales, with estimates far above consensus—53% for Macs and 52% for iPads. She also expects Apple to increase its dividend by 10% and expand its stock repurchase program by $60 billion.\nThat would certainly qualify as a job well done.","news_type":1},"isVote":1,"tweetType":1,"viewCount":152,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377821308,"gmtCreate":1619516229204,"gmtModify":1704725240447,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Let’s bring it higher","listText":"Let’s bring it higher","text":"Let’s bring it higher","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/377821308","repostId":"2130434518","repostType":2,"repost":{"id":"2130434518","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1619473682,"share":"https://ttm.financial/m/news/2130434518?lang=&edition=fundamental","pubTime":"2021-04-27 05:48","market":"us","language":"en","title":"MicroVision soars 47%, leading 'meme stocks' higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2130434518","media":"Reuters","summary":"(Reuters) - Shares of laser-developer MicroVision Inc jumped 47% on Monday and other Reddit favorite","content":"<p>(Reuters) - Shares of laser-developer MicroVision Inc jumped 47% on Monday and other Reddit favorites rallied, suggesting that interest in so-called meme stocks remains strong after a wild ride this year.</p>\n<p>MicroVision, which develops laser scanning technology for automotive lidar sensors and augmented reality, was the most mentioned stock on Reddit's popular WallStreetBets forum on Monday, according to sentiment tracker SwaggyStocks.</p>\n<p>Other so-called meme stocks, which have been a focus on WallStreetBets and other online forums populated by retail traders, were also higher on Monday, including GameStop, AMC Entertainment and Koss Corp.</p>\n<p>\"I think it's retail coming back in to start the week,\" said Rick Meckler, partner, Cherry Lane Investments, a family investment office in New Vernon, New Jersey. \"The meme stocks tend to be more emotional for investors and very momentum driven.\"</p>\n<p>Meme stocks grabbed the spotlight earlier this year, when a flurry of buying in the shares of video game retailer GameStop forced bearish investors to unwind their bets against the stock, sparking a nearly 1700% rally and surges in other Reddit-favorites in January.</p>\n<p>Trading in the names has been highly volatile in the last few months, though GameStop shares are still up nearly 800% on the year.</p>\n<p>\"This market has been highly speculative at the edges for months. Retail interest appears to remain strong for high-beta speculative names,\" Meckler said.</p>\n<p>MicroVision shares closed at $26.44 on Monday after rising as high as $27.80 during the high-volume trading session. The stock is up 391% year-to-date.</p>\n<p>In the past, investors have been particularly sensitive to news about the company's Long Range Lidar Sensor technology and the company has set expectations that it could complete samples of the technology within its April timeframe.</p>\n<p>Short interest in MicroVision stood at about 18.7% of the float, with 29.37 million of the company's stock sold short as of Friday's close, according to S3 Partners.</p>\n<p>The number of shares shorted increased by 1.4 million in the last seven days, showing some investors placed bearish bets as the shares have rallied, said S3's Ihor Dusaniwsky.</p>\n<p>\"We are seeing shorting into a red-hot stock as shorts are looking for a pullback,\" Dusaniwsky said.</p>\n<p>But bearish investors could be \"squeezed out of their positions due to losses\" if the shares continue rallying, he said.</p>\n<p>In Monday's trading alone, short sellers were showing mark-to-market losses of $227 million on the day when the stock was trading at $25.69, Dusaniwsky said.</p>\n<p>Short seller Hindenburg Research said in a Dec. 22 <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> post that it was betting against the company's shares. It did not reply to a request for comment on Monday.</p>\n<p>MicroVision's options were the sixth most active among single stock names on Monday, with heavy trading in call options betting on the stock to gain another 30% by mid-May, according to Trade Alert.</p>\n<p>The company is due to report results on April 29. A representative for MicroVision said on Monday that the company does not comment on movements in its share price.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroVision soars 47%, leading 'meme stocks' higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroVision soars 47%, leading 'meme stocks' higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-27 05:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Reuters) - Shares of laser-developer MicroVision Inc jumped 47% on Monday and other Reddit favorites rallied, suggesting that interest in so-called meme stocks remains strong after a wild ride this year.</p>\n<p>MicroVision, which develops laser scanning technology for automotive lidar sensors and augmented reality, was the most mentioned stock on Reddit's popular WallStreetBets forum on Monday, according to sentiment tracker SwaggyStocks.</p>\n<p>Other so-called meme stocks, which have been a focus on WallStreetBets and other online forums populated by retail traders, were also higher on Monday, including GameStop, AMC Entertainment and Koss Corp.</p>\n<p>\"I think it's retail coming back in to start the week,\" said Rick Meckler, partner, Cherry Lane Investments, a family investment office in New Vernon, New Jersey. \"The meme stocks tend to be more emotional for investors and very momentum driven.\"</p>\n<p>Meme stocks grabbed the spotlight earlier this year, when a flurry of buying in the shares of video game retailer GameStop forced bearish investors to unwind their bets against the stock, sparking a nearly 1700% rally and surges in other Reddit-favorites in January.</p>\n<p>Trading in the names has been highly volatile in the last few months, though GameStop shares are still up nearly 800% on the year.</p>\n<p>\"This market has been highly speculative at the edges for months. Retail interest appears to remain strong for high-beta speculative names,\" Meckler said.</p>\n<p>MicroVision shares closed at $26.44 on Monday after rising as high as $27.80 during the high-volume trading session. The stock is up 391% year-to-date.</p>\n<p>In the past, investors have been particularly sensitive to news about the company's Long Range Lidar Sensor technology and the company has set expectations that it could complete samples of the technology within its April timeframe.</p>\n<p>Short interest in MicroVision stood at about 18.7% of the float, with 29.37 million of the company's stock sold short as of Friday's close, according to S3 Partners.</p>\n<p>The number of shares shorted increased by 1.4 million in the last seven days, showing some investors placed bearish bets as the shares have rallied, said S3's Ihor Dusaniwsky.</p>\n<p>\"We are seeing shorting into a red-hot stock as shorts are looking for a pullback,\" Dusaniwsky said.</p>\n<p>But bearish investors could be \"squeezed out of their positions due to losses\" if the shares continue rallying, he said.</p>\n<p>In Monday's trading alone, short sellers were showing mark-to-market losses of $227 million on the day when the stock was trading at $25.69, Dusaniwsky said.</p>\n<p>Short seller Hindenburg Research said in a Dec. 22 <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> post that it was betting against the company's shares. It did not reply to a request for comment on Monday.</p>\n<p>MicroVision's options were the sixth most active among single stock names on Monday, with heavy trading in call options betting on the stock to gain another 30% by mid-May, according to Trade Alert.</p>\n<p>The company is due to report results on April 29. A representative for MicroVision said on Monday that the company does not comment on movements in its share price.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MVIS":"维视图像","GME":"游戏驿站"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2130434518","content_text":"(Reuters) - Shares of laser-developer MicroVision Inc jumped 47% on Monday and other Reddit favorites rallied, suggesting that interest in so-called meme stocks remains strong after a wild ride this year.\nMicroVision, which develops laser scanning technology for automotive lidar sensors and augmented reality, was the most mentioned stock on Reddit's popular WallStreetBets forum on Monday, according to sentiment tracker SwaggyStocks.\nOther so-called meme stocks, which have been a focus on WallStreetBets and other online forums populated by retail traders, were also higher on Monday, including GameStop, AMC Entertainment and Koss Corp.\n\"I think it's retail coming back in to start the week,\" said Rick Meckler, partner, Cherry Lane Investments, a family investment office in New Vernon, New Jersey. \"The meme stocks tend to be more emotional for investors and very momentum driven.\"\nMeme stocks grabbed the spotlight earlier this year, when a flurry of buying in the shares of video game retailer GameStop forced bearish investors to unwind their bets against the stock, sparking a nearly 1700% rally and surges in other Reddit-favorites in January.\nTrading in the names has been highly volatile in the last few months, though GameStop shares are still up nearly 800% on the year.\n\"This market has been highly speculative at the edges for months. Retail interest appears to remain strong for high-beta speculative names,\" Meckler said.\nMicroVision shares closed at $26.44 on Monday after rising as high as $27.80 during the high-volume trading session. The stock is up 391% year-to-date.\nIn the past, investors have been particularly sensitive to news about the company's Long Range Lidar Sensor technology and the company has set expectations that it could complete samples of the technology within its April timeframe.\nShort interest in MicroVision stood at about 18.7% of the float, with 29.37 million of the company's stock sold short as of Friday's close, according to S3 Partners.\nThe number of shares shorted increased by 1.4 million in the last seven days, showing some investors placed bearish bets as the shares have rallied, said S3's Ihor Dusaniwsky.\n\"We are seeing shorting into a red-hot stock as shorts are looking for a pullback,\" Dusaniwsky said.\nBut bearish investors could be \"squeezed out of their positions due to losses\" if the shares continue rallying, he said.\nIn Monday's trading alone, short sellers were showing mark-to-market losses of $227 million on the day when the stock was trading at $25.69, Dusaniwsky said.\nShort seller Hindenburg Research said in a Dec. 22 Twitter post that it was betting against the company's shares. It did not reply to a request for comment on Monday.\nMicroVision's options were the sixth most active among single stock names on Monday, with heavy trading in call options betting on the stock to gain another 30% by mid-May, according to Trade Alert.\nThe company is due to report results on April 29. A representative for MicroVision said on Monday that the company does not comment on movements in its share price.","news_type":1},"isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374832788,"gmtCreate":1619436674544,"gmtModify":1704723799828,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Let hot 1k this time round&nbsp;","listText":"Let hot 1k this time round&nbsp;","text":"Let hot 1k this time round","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/374832788","repostId":"2130364766","repostType":4,"repost":{"id":"2130364766","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1619318325,"share":"https://ttm.financial/m/news/2130364766?lang=&edition=fundamental","pubTime":"2021-04-25 10:38","market":"us","language":"en","title":"What to Expect From Tesla's Q1 Earnings Report On Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2130364766","media":"Benzinga","summary":"EV giant Tesla, Inc.  is scheduled to release its first-quarter results Monday, after the market close.Key Q1 Metrics to Watch For:  Tesla is expected to report non-GAAP earnings per share, or EPS, of 79 cents in the first quarter of 2021, up sharply from 23 cents in the year-ago quarter.The consensus revenue forecast for the quarter is at $10.29 billion, up 72% year-over-year.Focus On Regulatory Credits, Automotive Margins:  The focus is likely to be on regulatory credits, which accounted for 4","content":"<p><img src=\"https://static.tigerbbs.com/fe458ac1cf82668bd4bf27fbaa6506e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p><p>EV giant <b>Tesla, Inc. </b>(NASDAQ: TSLA) is scheduled to release its first-quarter results Monday, after the market close.</p><p><b>Key Q1 Metrics to Watch For: </b> Tesla is expected to report non-GAAP earnings per share, or EPS, of 79 cents in the first quarter of 2021, up sharply from 23 cents in the year-ago quarter.</p><p>The consensus revenue forecast for the quarter is at $10.29 billion, up 72% year-over-year.</p><p>In the fourth quarter, Tesla had earned 80 cents per share on a non-GAAP basis on revenues of $10.74 billion.</p><p>Tesla revealed in early April it delivered a record 184,800 vehicles in the first quarter, comprising 182,780 Model 3/Y vehicles and 2,020 Model S/X vehicles. This represents a 109% year-over-year increase and 2.2% sequential growth. Quarterly production was at 180,338.</p><p><b>Focus On Regulatory Credits, Automotive Margins: </b> The focus is likely to be on regulatory credits, which accounted for 4.3% of its revenues in the fourth quarter of 2020. Zero-emission vehicle regulations adopted by several states allow EV manufacturers to&nbsp;earn regulatory credits, which can be monetized by selling to legacy automakers, who are not able to achieve the minimum target set for the proportion of green energy vehicles sold.</p><p>Automotive gross margin slipped to 24.1% in the fourth quarter of 2020 from 27.7% in the previous quarter. It's likely the company could see a further moderation in margins, as production of the higher priced Model S/X vehicles was stalled in the quarter to allow for model refreshes.</p><p><b>View more earnings on TSLA</b></p><p>With competitive pressure intensifying, Tesla could aggressively slash vehicles prices in order to achieve volume production targets, long-time Tesla bear Gordon Johnson said in a note previewing the quarterly results.</p><p>Tesla investors may also be keen to find out more about the company's Bitcoin investment strategy and its decision to allow the use of Bitcoin for vehicle purchases.</p><p><b>Forward Outlook:</b> Tesla is well positioned to capitalize on the opportunity presented by the exponential growth that is anticipated for green energy vehicles.<b> </b>Its&nbsp;Giga Shanghai factory is now churning out both Model S and Model Y vehicles, and more capacity is expected to come on line with the opening of factories in Berlin and Texas.</p><p>Tesla's CFO Zach Kirkhorn said on the earnings call that the company is shooting for a 50% compounded annual growth rate in volume sales&nbsp;and expects to materially exceed the target in 2021.</p><p><b>Stock Take: </b> Tesla's shares, which were flying high until early February, joined the tech sell-off that ensued. From a split-adjusted high of $900.40 on Jan. 25, the stock fell to $539.49 on March 5, a peak-to-trough decline of 40%.</p><p>Although the stock has made good some of the losses since then, it is yet to break above $800 level.</p><p>Tesla holds a several-year lead and is now expanding aggressively into storage, and therefore a premium valuation for its shares is justified, CANACCORD Genuity analyst Jed Dorsheimer said in a recent note. The firm has a $1,071 price target for the stock.</p><p>Friday, Tesla's shares ended 1.35% higher at $729.40.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What to Expect From Tesla's Q1 Earnings Report On Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat to Expect From Tesla's Q1 Earnings Report On Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-04-25 10:38</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><img src=\"https://static.tigerbbs.com/fe458ac1cf82668bd4bf27fbaa6506e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p><p>EV giant <b>Tesla, Inc. </b>(NASDAQ: TSLA) is scheduled to release its first-quarter results Monday, after the market close.</p><p><b>Key Q1 Metrics to Watch For: </b> Tesla is expected to report non-GAAP earnings per share, or EPS, of 79 cents in the first quarter of 2021, up sharply from 23 cents in the year-ago quarter.</p><p>The consensus revenue forecast for the quarter is at $10.29 billion, up 72% year-over-year.</p><p>In the fourth quarter, Tesla had earned 80 cents per share on a non-GAAP basis on revenues of $10.74 billion.</p><p>Tesla revealed in early April it delivered a record 184,800 vehicles in the first quarter, comprising 182,780 Model 3/Y vehicles and 2,020 Model S/X vehicles. This represents a 109% year-over-year increase and 2.2% sequential growth. Quarterly production was at 180,338.</p><p><b>Focus On Regulatory Credits, Automotive Margins: </b> The focus is likely to be on regulatory credits, which accounted for 4.3% of its revenues in the fourth quarter of 2020. Zero-emission vehicle regulations adopted by several states allow EV manufacturers to&nbsp;earn regulatory credits, which can be monetized by selling to legacy automakers, who are not able to achieve the minimum target set for the proportion of green energy vehicles sold.</p><p>Automotive gross margin slipped to 24.1% in the fourth quarter of 2020 from 27.7% in the previous quarter. It's likely the company could see a further moderation in margins, as production of the higher priced Model S/X vehicles was stalled in the quarter to allow for model refreshes.</p><p><b>View more earnings on TSLA</b></p><p>With competitive pressure intensifying, Tesla could aggressively slash vehicles prices in order to achieve volume production targets, long-time Tesla bear Gordon Johnson said in a note previewing the quarterly results.</p><p>Tesla investors may also be keen to find out more about the company's Bitcoin investment strategy and its decision to allow the use of Bitcoin for vehicle purchases.</p><p><b>Forward Outlook:</b> Tesla is well positioned to capitalize on the opportunity presented by the exponential growth that is anticipated for green energy vehicles.<b> </b>Its&nbsp;Giga Shanghai factory is now churning out both Model S and Model Y vehicles, and more capacity is expected to come on line with the opening of factories in Berlin and Texas.</p><p>Tesla's CFO Zach Kirkhorn said on the earnings call that the company is shooting for a 50% compounded annual growth rate in volume sales&nbsp;and expects to materially exceed the target in 2021.</p><p><b>Stock Take: </b> Tesla's shares, which were flying high until early February, joined the tech sell-off that ensued. From a split-adjusted high of $900.40 on Jan. 25, the stock fell to $539.49 on March 5, a peak-to-trough decline of 40%.</p><p>Although the stock has made good some of the losses since then, it is yet to break above $800 level.</p><p>Tesla holds a several-year lead and is now expanding aggressively into storage, and therefore a premium valuation for its shares is justified, CANACCORD Genuity analyst Jed Dorsheimer said in a recent note. The firm has a $1,071 price target for the stock.</p><p>Friday, Tesla's shares ended 1.35% higher at $729.40.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2130364766","content_text":"EV giant Tesla, Inc. (NASDAQ: TSLA) is scheduled to release its first-quarter results Monday, after the market close.Key Q1 Metrics to Watch For:  Tesla is expected to report non-GAAP earnings per share, or EPS, of 79 cents in the first quarter of 2021, up sharply from 23 cents in the year-ago quarter.The consensus revenue forecast for the quarter is at $10.29 billion, up 72% year-over-year.In the fourth quarter, Tesla had earned 80 cents per share on a non-GAAP basis on revenues of $10.74 billion.Tesla revealed in early April it delivered a record 184,800 vehicles in the first quarter, comprising 182,780 Model 3/Y vehicles and 2,020 Model S/X vehicles. This represents a 109% year-over-year increase and 2.2% sequential growth. Quarterly production was at 180,338.Focus On Regulatory Credits, Automotive Margins:  The focus is likely to be on regulatory credits, which accounted for 4.3% of its revenues in the fourth quarter of 2020. Zero-emission vehicle regulations adopted by several states allow EV manufacturers to earn regulatory credits, which can be monetized by selling to legacy automakers, who are not able to achieve the minimum target set for the proportion of green energy vehicles sold.Automotive gross margin slipped to 24.1% in the fourth quarter of 2020 from 27.7% in the previous quarter. It's likely the company could see a further moderation in margins, as production of the higher priced Model S/X vehicles was stalled in the quarter to allow for model refreshes.View more earnings on TSLAWith competitive pressure intensifying, Tesla could aggressively slash vehicles prices in order to achieve volume production targets, long-time Tesla bear Gordon Johnson said in a note previewing the quarterly results.Tesla investors may also be keen to find out more about the company's Bitcoin investment strategy and its decision to allow the use of Bitcoin for vehicle purchases.Forward Outlook: Tesla is well positioned to capitalize on the opportunity presented by the exponential growth that is anticipated for green energy vehicles. Its Giga Shanghai factory is now churning out both Model S and Model Y vehicles, and more capacity is expected to come on line with the opening of factories in Berlin and Texas.Tesla's CFO Zach Kirkhorn said on the earnings call that the company is shooting for a 50% compounded annual growth rate in volume sales and expects to materially exceed the target in 2021.Stock Take:  Tesla's shares, which were flying high until early February, joined the tech sell-off that ensued. From a split-adjusted high of $900.40 on Jan. 25, the stock fell to $539.49 on March 5, a peak-to-trough decline of 40%.Although the stock has made good some of the losses since then, it is yet to break above $800 level.Tesla holds a several-year lead and is now expanding aggressively into storage, and therefore a premium valuation for its shares is justified, CANACCORD Genuity analyst Jed Dorsheimer said in a recent note. The firm has a $1,071 price target for the stock.Friday, Tesla's shares ended 1.35% higher at $729.40.","news_type":1},"isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":372309058,"gmtCreate":1619173414974,"gmtModify":1704720768522,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Hope telsa share price will go up again.","listText":"Hope telsa share price will go up again.","text":"Hope telsa share price will go up again.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/372309058","repostId":"1139313098","repostType":4,"repost":{"id":"1139313098","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1619166809,"share":"https://ttm.financial/m/news/1139313098?lang=&edition=fundamental","pubTime":"2021-04-23 16:33","market":"us","language":"en","title":"Will Tesla Shanghai Auto Show Incident Be A 'Watershed Event' For Rise Of Local Rivals Like Nio, Xpeng?","url":"https://stock-news.laohu8.com/highlight/detail?id=1139313098","media":"Benzinga","summary":"A protest incident related to alleged brake failure in a Tesla Inc vehicle in China is being seen as","content":"<p>A protest incident related to alleged brake failure in a&nbsp;<b>Tesla Inc</b>&nbsp;vehicle&nbsp;in China is being seen as synonymous with that of Samsung Galaxy Note 7’s exploding batteries saga and could be a watershed moment for the rise of electric car maker’s Asian rivals, cnEV postreportedon Thursday.</p>\n<p><b>What Happened:</b>The report cited Brian Shen, a former vice president at the Chinese smartphone giant OPPO, who has drawn parallels between the two incidents and sees it as a significant moment for both Tesla and its upcoming rivals in China such as&nbsp;<b>Nio Inc,Xpeng Inc</b>, and&nbsp;<b>Li Auto Inc.</b>.</p>\n<p>“When we look at the Tesla brake incident in a few years, will it be as significant as the Samsung Note 7 battery incident and become a watershed event for the rise of local new energy brands,” Shen wrote on Weibo, a Chinese microblogging site.</p>\n<p>Samsung Group’s Galaxy Note 7 that was launched in 2016 came under the global spotlight after incidents of battery overheating and explosion turned into a safety risk and also a logistics nightmare for airlines and airports across the world.</p>\n<p><b>Why It Matters:</b>Earlier this week, a woman&nbsp;climbed on a red Model 3&nbsp;at the Shanghai Auto Show wearing a white T-shirt with a message written in Chinese that read “Brake Lost Control.”</p>\n<p>The incident captured Chinese media and authorities' attention who questioned Tesla’s stand, eventually forcing the Elon Musk-led company to issue an apology.</p>\n<p>State-run media, including China's Central Commission for Political and Legal Affairs and Xinhua, questioned Tesla's stance, terming it as arrogance and betraying the faith placed in Tesla by Chinese consumers.</p>\n<p>Tesla continues to have a dominant position in the electric vehicle category but several Chinese players are closing in fast as newer entrants eye the lucrative EV opportunity.</p>\n<p>Tesla has run into other troubles with&nbsp;authorities in China as well, with vehicles made by it&nbsp;being denied access&nbsp;to military-owned facilities on grounds that cameras installed in the vehicles could&nbsp;collect sensitive information.</p>\n<p><b>Price Action:</b>Tesla shares closed 3.28% lower at $719.69 on Thursday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Tesla Shanghai Auto Show Incident Be A 'Watershed Event' For Rise Of Local Rivals Like Nio, Xpeng?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Tesla Shanghai Auto Show Incident Be A 'Watershed Event' For Rise Of Local Rivals Like Nio, Xpeng?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-04-23 16:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>A protest incident related to alleged brake failure in a&nbsp;<b>Tesla Inc</b>&nbsp;vehicle&nbsp;in China is being seen as synonymous with that of Samsung Galaxy Note 7’s exploding batteries saga and could be a watershed moment for the rise of electric car maker’s Asian rivals, cnEV postreportedon Thursday.</p>\n<p><b>What Happened:</b>The report cited Brian Shen, a former vice president at the Chinese smartphone giant OPPO, who has drawn parallels between the two incidents and sees it as a significant moment for both Tesla and its upcoming rivals in China such as&nbsp;<b>Nio Inc,Xpeng Inc</b>, and&nbsp;<b>Li Auto Inc.</b>.</p>\n<p>“When we look at the Tesla brake incident in a few years, will it be as significant as the Samsung Note 7 battery incident and become a watershed event for the rise of local new energy brands,” Shen wrote on Weibo, a Chinese microblogging site.</p>\n<p>Samsung Group’s Galaxy Note 7 that was launched in 2016 came under the global spotlight after incidents of battery overheating and explosion turned into a safety risk and also a logistics nightmare for airlines and airports across the world.</p>\n<p><b>Why It Matters:</b>Earlier this week, a woman&nbsp;climbed on a red Model 3&nbsp;at the Shanghai Auto Show wearing a white T-shirt with a message written in Chinese that read “Brake Lost Control.”</p>\n<p>The incident captured Chinese media and authorities' attention who questioned Tesla’s stand, eventually forcing the Elon Musk-led company to issue an apology.</p>\n<p>State-run media, including China's Central Commission for Political and Legal Affairs and Xinhua, questioned Tesla's stance, terming it as arrogance and betraying the faith placed in Tesla by Chinese consumers.</p>\n<p>Tesla continues to have a dominant position in the electric vehicle category but several Chinese players are closing in fast as newer entrants eye the lucrative EV opportunity.</p>\n<p>Tesla has run into other troubles with&nbsp;authorities in China as well, with vehicles made by it&nbsp;being denied access&nbsp;to military-owned facilities on grounds that cameras installed in the vehicles could&nbsp;collect sensitive information.</p>\n<p><b>Price Action:</b>Tesla shares closed 3.28% lower at $719.69 on Thursday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","TSLA":"特斯拉","LI":"理想汽车","XPEV":"小鹏汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139313098","content_text":"A protest incident related to alleged brake failure in a Tesla Inc vehicle in China is being seen as synonymous with that of Samsung Galaxy Note 7’s exploding batteries saga and could be a watershed moment for the rise of electric car maker’s Asian rivals, cnEV postreportedon Thursday.\nWhat Happened:The report cited Brian Shen, a former vice president at the Chinese smartphone giant OPPO, who has drawn parallels between the two incidents and sees it as a significant moment for both Tesla and its upcoming rivals in China such as Nio Inc,Xpeng Inc, and Li Auto Inc..\n“When we look at the Tesla brake incident in a few years, will it be as significant as the Samsung Note 7 battery incident and become a watershed event for the rise of local new energy brands,” Shen wrote on Weibo, a Chinese microblogging site.\nSamsung Group’s Galaxy Note 7 that was launched in 2016 came under the global spotlight after incidents of battery overheating and explosion turned into a safety risk and also a logistics nightmare for airlines and airports across the world.\nWhy It Matters:Earlier this week, a woman climbed on a red Model 3 at the Shanghai Auto Show wearing a white T-shirt with a message written in Chinese that read “Brake Lost Control.”\nThe incident captured Chinese media and authorities' attention who questioned Tesla’s stand, eventually forcing the Elon Musk-led company to issue an apology.\nState-run media, including China's Central Commission for Political and Legal Affairs and Xinhua, questioned Tesla's stance, terming it as arrogance and betraying the faith placed in Tesla by Chinese consumers.\nTesla continues to have a dominant position in the electric vehicle category but several Chinese players are closing in fast as newer entrants eye the lucrative EV opportunity.\nTesla has run into other troubles with authorities in China as well, with vehicles made by it being denied access to military-owned facilities on grounds that cameras installed in the vehicles could collect sensitive information.\nPrice Action:Tesla shares closed 3.28% lower at $719.69 on Thursday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345489210,"gmtCreate":1618329620830,"gmtModify":1704709324496,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"Which 1 is good to invest","listText":"Which 1 is good to invest","text":"Which 1 is good to invest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/345489210","repostId":"1132245191","repostType":4,"repost":{"id":"1132245191","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1618328738,"share":"https://ttm.financial/m/news/1132245191?lang=&edition=fundamental","pubTime":"2021-04-13 23:45","market":"us","language":"en","title":"Who Wants To Own The 2 Hottest SPAC Domains, SPAC.com And SPACs.com?","url":"https://stock-news.laohu8.com/highlight/detail?id=1132245191","media":"Benzinga","summary":"The Gist: If you’ve been following the markets in 2021, you surely have heard of SPACs.Well, today, ","content":"<p><b>The Gist:</b>&nbsp;If you’ve been following the markets in 2021, you surely have heard of SPACs.</p><p>Well, today, in my column, I have a whopper for you. Here’s your chance to own the metaphorical Boardwalk or Park Place of Spac domain world.</p><p><b>What Are SPACs:</b>&nbsp;In 2020, special purpose acquisition companies, or SPACs, accounted for nearly 50% of the IPO market.</p><p>The reason why? SPACs make the go-public process more seamless and timely. The entity raises capital, through a public offering, and later uses it to fund acquisitions. Investors enjoy limited downside; if funds are not used in an acquisition, proceeds are returned.</p><p>Andrew Miller, a domain name entrepreneur, is looking to capitalize on go-public trends with the listing of two web addresses,SPAC.comandSPACs.com, for sale.</p><p><b>What Happened:</b>&nbsp;Miller, known for foundingCreditCards.comandInsuranceQuotes.com, is an active advisor and shareholder in Thrasio and president at ATM Holdings.</p><p>In 2021, Miller oversaw the acquisition of one of the most valuable domain names on the Internet,Home.com, for Fairway Independent Mortgage. The entrepreneur also worked withCMCSA 0.85%NBC Universal over the acquisition ofBetcast.com.</p><p>“The SPAC initiative is disrupting the way very successful companies, like DraftKings, go public, and a SPAC may very well supersede IPO as the branded word for going public,” Miller told Benzinga.</p><p>“These domains position the new owner to immediately be the authoritative, most credible market leader,” he said in a discussion on brands owning easy-to-remember domains. “Domains are the original non-fungible tokens or NFTs, and the market strength is being driven daily by Fortune 500, venture, and private equity businesses.”</p><p><b>Why It Matters:</b>&nbsp;In light of emerging trends in finance, such as the decision by more businesses to go public via the SPAC route, or consumers and producers assigning and transferring value using new concepts like NFTs, or tokens that represent digital certificates of ownership, it pays to participate in the buying and selling of domains.</p><p>For instance, in 2020,<b>MicroStrategy Incorporated</b>MSTR 9.08%soldVoice.comfor $30 million. Also of importance — brands likeBAC 1.25%ownsLoans.com, Fidelity ownsFunds.com, whileAMZN 1.41%acquiredPodcast.comandStreaming.com. Of course,Booking.comHotels.com</p><p>“Hear it once, remember it forever,” Miller told Benzinga.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Who Wants To Own The 2 Hottest SPAC Domains, SPAC.com And SPACs.com?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWho Wants To Own The 2 Hottest SPAC Domains, SPAC.com And SPACs.com?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-04-13 23:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>The Gist:</b>&nbsp;If you’ve been following the markets in 2021, you surely have heard of SPACs.</p><p>Well, today, in my column, I have a whopper for you. Here’s your chance to own the metaphorical Boardwalk or Park Place of Spac domain world.</p><p><b>What Are SPACs:</b>&nbsp;In 2020, special purpose acquisition companies, or SPACs, accounted for nearly 50% of the IPO market.</p><p>The reason why? SPACs make the go-public process more seamless and timely. The entity raises capital, through a public offering, and later uses it to fund acquisitions. Investors enjoy limited downside; if funds are not used in an acquisition, proceeds are returned.</p><p>Andrew Miller, a domain name entrepreneur, is looking to capitalize on go-public trends with the listing of two web addresses,SPAC.comandSPACs.com, for sale.</p><p><b>What Happened:</b>&nbsp;Miller, known for foundingCreditCards.comandInsuranceQuotes.com, is an active advisor and shareholder in Thrasio and president at ATM Holdings.</p><p>In 2021, Miller oversaw the acquisition of one of the most valuable domain names on the Internet,Home.com, for Fairway Independent Mortgage. The entrepreneur also worked withCMCSA 0.85%NBC Universal over the acquisition ofBetcast.com.</p><p>“The SPAC initiative is disrupting the way very successful companies, like DraftKings, go public, and a SPAC may very well supersede IPO as the branded word for going public,” Miller told Benzinga.</p><p>“These domains position the new owner to immediately be the authoritative, most credible market leader,” he said in a discussion on brands owning easy-to-remember domains. “Domains are the original non-fungible tokens or NFTs, and the market strength is being driven daily by Fortune 500, venture, and private equity businesses.”</p><p><b>Why It Matters:</b>&nbsp;In light of emerging trends in finance, such as the decision by more businesses to go public via the SPAC route, or consumers and producers assigning and transferring value using new concepts like NFTs, or tokens that represent digital certificates of ownership, it pays to participate in the buying and selling of domains.</p><p>For instance, in 2020,<b>MicroStrategy Incorporated</b>MSTR 9.08%soldVoice.comfor $30 million. Also of importance — brands likeBAC 1.25%ownsLoans.com, Fidelity ownsFunds.com, whileAMZN 1.41%acquiredPodcast.comandStreaming.com. Of course,Booking.comHotels.com</p><p>“Hear it once, remember it forever,” Miller told Benzinga.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132245191","content_text":"The Gist: If you’ve been following the markets in 2021, you surely have heard of SPACs.Well, today, in my column, I have a whopper for you. Here’s your chance to own the metaphorical Boardwalk or Park Place of Spac domain world.What Are SPACs: In 2020, special purpose acquisition companies, or SPACs, accounted for nearly 50% of the IPO market.The reason why? SPACs make the go-public process more seamless and timely. The entity raises capital, through a public offering, and later uses it to fund acquisitions. Investors enjoy limited downside; if funds are not used in an acquisition, proceeds are returned.Andrew Miller, a domain name entrepreneur, is looking to capitalize on go-public trends with the listing of two web addresses,SPAC.comandSPACs.com, for sale.What Happened: Miller, known for foundingCreditCards.comandInsuranceQuotes.com, is an active advisor and shareholder in Thrasio and president at ATM Holdings.In 2021, Miller oversaw the acquisition of one of the most valuable domain names on the Internet,Home.com, for Fairway Independent Mortgage. The entrepreneur also worked withCMCSA 0.85%NBC Universal over the acquisition ofBetcast.com.“The SPAC initiative is disrupting the way very successful companies, like DraftKings, go public, and a SPAC may very well supersede IPO as the branded word for going public,” Miller told Benzinga.“These domains position the new owner to immediately be the authoritative, most credible market leader,” he said in a discussion on brands owning easy-to-remember domains. “Domains are the original non-fungible tokens or NFTs, and the market strength is being driven daily by Fortune 500, venture, and private equity businesses.”Why It Matters: In light of emerging trends in finance, such as the decision by more businesses to go public via the SPAC route, or consumers and producers assigning and transferring value using new concepts like NFTs, or tokens that represent digital certificates of ownership, it pays to participate in the buying and selling of domains.For instance, in 2020,MicroStrategy IncorporatedMSTR 9.08%soldVoice.comfor $30 million. Also of importance — brands likeBAC 1.25%ownsLoans.com, Fidelity ownsFunds.com, whileAMZN 1.41%acquiredPodcast.comandStreaming.com. Of course,Booking.comHotels.com“Hear it once, remember it forever,” Miller told Benzinga.","news_type":1},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":348125767,"gmtCreate":1617895478959,"gmtModify":1704704586470,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"When is telsa going to 1000","listText":"When is telsa going to 1000","text":"When is telsa going to 1000","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/348125767","repostId":"1143928842","repostType":4,"repost":{"id":"1143928842","kind":"news","pubTimestamp":1617893886,"share":"https://ttm.financial/m/news/1143928842?lang=&edition=fundamental","pubTime":"2021-04-08 22:58","market":"us","language":"en","title":"Tesla CEO Elon Musk Weighs In on Chip Shortage—Maybe","url":"https://stock-news.laohu8.com/highlight/detail?id=1143928842","media":"Barrons","summary":"The global automotive supply chain has been roiled in 2021 by an unusual microchip shortage. Everyon","content":"<p>The global automotive supply chain has been roiled in 2021 by an unusual microchip shortage. Everyone is talking about it, from Wall Street analysts to auto makers to auto suppliers. Even auto dealers are talking about the impact of the shortage on their businesses.</p>\n<p>Everyone is talking about it, that is, except&nbsp;Tesla(ticker: TSLA). The electric-vehicle maker is notoriously tight-lipped about almost everything. CEO&nbsp;Elon Musk&nbsp;isn’t, though, and a Thursday tweet seems to indicate that things might be going better for Tesla than for its rivals. That could show up in Tesla’s second-quarter earnings, which are due in late April.</p>\n<p>It wasn’t a long orcontroversial tweet. Just one that thanked suppliers for getting Tesla critical parts. “This could be important,” Tesla investorGary Blacktells<i>Barron’s</i>. Black is a former Wall Street analyst and former executive at Goldman Sachs Asset Management. He is an important voice on Tesla stock, and more than 71,000 Twitter followers listen to his views on the EV industry. The tweet means “either that 1Q results weren’t impacted by the chip shortage, or that issues holding back production [and] deliveries of new S/X resolved,” Black says.</p>\n<p>Tesla produced zero Model S and X vehicles in the first quarter. Both vehicles are due for a product “refresh”—an upgrade in looks, features, and interiors. The refresh might have affected production, or the company may have simply allocated a limited number of chips to higher-volume models.</p>\n<p>Reduced production and product prioritization aren’t surprises.General Motor(GM) and&nbsp;Ford Motor(F) have already called the chip shortage a billion-dollar headwind to 2021 profits. GM and Ford—along with a host of other auto makers, including Chinese EV maker&nbsp;NIO(NIO)—have seen production impacted by a lack of parts.</p>\n<p>Black believes Musk’s tweet is a bullish sign, but he qualifies as a Tesla bull. He’s owned the stock for long stretches and has a $960 price target for shares. Morgan Stanley analyst&nbsp;Adam Jonas&nbsp;is also a bull, rating shares Buy with an $880 price target. He weighed into the parts-shortage debate Thursday with another take: Tesla might be a beneficiary of recent developments, but they aren’t the only one.</p>\n<p>He sees far wider-ranging impacts from the chip shortage than just reduced production. “We are seeing levels of light vehicle inventory tightness that goes beyond anything we have ever seen,” wrote Jonas in a Wednesday evening report. Both used- and new-car pricing are getting a huge boost from a lack of cars. Dealers are telling Jonas many vehicles are selling at “list plus” pricing.</p>\n<p>And Jonas sees the positive effects of the shortage stretching into 2022. This year “is a year of contained volume and strong price/mix,” writes the analyst, adding that “2022 is setting up to be a year of satiated volume [and] pent up demand.”</p>\n<p>Positives outweighing negative might be one reason GM and Ford stocks are on fire. Both are up more than 40% year to date, easily beating the comparable returns of the&nbsp;S&amp;P 500&nbsp;and&nbsp;Dow Jones Industrial Average.</p>\n<p>Tesla shares, however, aren’t doing nearly as well. The stock is down roughly 4% year to date and 25% from its January 52-week high. Solving the chip shortage problem faster than other auto makers might help Tesla stock make up some recent lost ground.</p>\n<p>Tesla stock was up 2.6%, at $688.50, in recent trading. The S&amp;P 500 was up 0.3%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla CEO Elon Musk Weighs In on Chip Shortage—Maybe</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla CEO Elon Musk Weighs In on Chip Shortage—Maybe\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-08 22:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-ceo-elon-musk-weighs-in-on-chip-shortagemaybe-51617893116?mod=RTA><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The global automotive supply chain has been roiled in 2021 by an unusual microchip shortage. Everyone is talking about it, from Wall Street analysts to auto makers to auto suppliers. Even auto dealers...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-ceo-elon-musk-weighs-in-on-chip-shortagemaybe-51617893116?mod=RTA\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-ceo-elon-musk-weighs-in-on-chip-shortagemaybe-51617893116?mod=RTA","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143928842","content_text":"The global automotive supply chain has been roiled in 2021 by an unusual microchip shortage. Everyone is talking about it, from Wall Street analysts to auto makers to auto suppliers. Even auto dealers are talking about the impact of the shortage on their businesses.\nEveryone is talking about it, that is, except Tesla(ticker: TSLA). The electric-vehicle maker is notoriously tight-lipped about almost everything. CEO Elon Musk isn’t, though, and a Thursday tweet seems to indicate that things might be going better for Tesla than for its rivals. That could show up in Tesla’s second-quarter earnings, which are due in late April.\nIt wasn’t a long orcontroversial tweet. Just one that thanked suppliers for getting Tesla critical parts. “This could be important,” Tesla investorGary BlacktellsBarron’s. Black is a former Wall Street analyst and former executive at Goldman Sachs Asset Management. He is an important voice on Tesla stock, and more than 71,000 Twitter followers listen to his views on the EV industry. The tweet means “either that 1Q results weren’t impacted by the chip shortage, or that issues holding back production [and] deliveries of new S/X resolved,” Black says.\nTesla produced zero Model S and X vehicles in the first quarter. Both vehicles are due for a product “refresh”—an upgrade in looks, features, and interiors. The refresh might have affected production, or the company may have simply allocated a limited number of chips to higher-volume models.\nReduced production and product prioritization aren’t surprises.General Motor(GM) and Ford Motor(F) have already called the chip shortage a billion-dollar headwind to 2021 profits. GM and Ford—along with a host of other auto makers, including Chinese EV maker NIO(NIO)—have seen production impacted by a lack of parts.\nBlack believes Musk’s tweet is a bullish sign, but he qualifies as a Tesla bull. He’s owned the stock for long stretches and has a $960 price target for shares. Morgan Stanley analyst Adam Jonas is also a bull, rating shares Buy with an $880 price target. He weighed into the parts-shortage debate Thursday with another take: Tesla might be a beneficiary of recent developments, but they aren’t the only one.\nHe sees far wider-ranging impacts from the chip shortage than just reduced production. “We are seeing levels of light vehicle inventory tightness that goes beyond anything we have ever seen,” wrote Jonas in a Wednesday evening report. Both used- and new-car pricing are getting a huge boost from a lack of cars. Dealers are telling Jonas many vehicles are selling at “list plus” pricing.\nAnd Jonas sees the positive effects of the shortage stretching into 2022. This year “is a year of contained volume and strong price/mix,” writes the analyst, adding that “2022 is setting up to be a year of satiated volume [and] pent up demand.”\nPositives outweighing negative might be one reason GM and Ford stocks are on fire. Both are up more than 40% year to date, easily beating the comparable returns of the S&P 500 and Dow Jones Industrial Average.\nTesla shares, however, aren’t doing nearly as well. The stock is down roughly 4% year to date and 25% from its January 52-week high. Solving the chip shortage problem faster than other auto makers might help Tesla stock make up some recent lost ground.\nTesla stock was up 2.6%, at $688.50, in recent trading. The S&P 500 was up 0.3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":37,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815222151,"gmtCreate":1630682018273,"gmtModify":1676530376184,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Please hit 800","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Please hit 800","text":"$Tesla Motors(TSLA)$Please hit 800","images":[{"img":"https://static.tigerbbs.com/d072a346ed5b0178d15b682d44f0f0c5","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815222151","isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}